WO2014124378A1

WO2014124378A1 - Curable silicone compositions comprising clustured functional polyorganosiloxanes and silicone reactive diluents

Info

Publication number: WO2014124378A1
Application number: PCT/US2014/015598
Authority: WO
Inventors: Jing Jiang; Yin Tang; James Tonge; Afrooz Zarisfi
Original assignee: Dow Corning Corporation
Priority date: 2013-02-11
Filing date: 2014-02-10
Publication date: 2014-08-14
Also published as: TW201500469A; TWI620795B; KR20150117268A; US20160032060A1; EP2954024A1; JP6426628B2; US9718925B2; CN104968751A; KR102170923B1; EP2954024B1; JP2016513151A; CN104968751B

Abstract

A curable silicone composition is provided that comprises a reaction product of a reaction of (I) a clustered functional polyorganopolysiloxane having at least one radical curable group selected from an acrylate group and a methacrylate group; (II) a silicone reactive diluent, and a (III) a radical initiator.

Description

CURABLE SILICONE COMPOSITIONS COMPRISING CLUSTURED FUNCTIONAL POLYORGANOSILOXANES AND SILICONE REACTIVE DILUENTS

[0001 ] The present invention relates generally to curable silicone compositions, and more specifically to curable silicone compositions comprising a reaction product of a reaction of (I) a clustered functional polyorganopolysiloxane having at least one radical curable group selected from an acrylate group and a methacrylate group; (II) a silicone reactive diluent, and a (III) a radical initiator.

[0002] Polyorganosiloxane compositions that cure to elastomeric materials are well known. Such compositions may be prepared by mixing polydiorganosiloxanes having curable (e.g., hydrolyzable, radiation curable, or heat curable) groups with crosslinking agents and/or catalysts, as needed. Generally, the polydiorganosiloxanes may have 1 to 3 reactive groups per chain end. Compositions including these components can then be cured, for example, by exposure to atmospheric moisture, exposure to radiation, or exposure to heat, depending on the curable groups present.

[0003] The cure rate of a particular composition depends on various factors including the type and number reactive group(s) present. It is known that different groups have different reactivities. For example, in the presence of moisture, a silicon-bonded acetoxy group will usually hydrolyze more rapidly than a silicon-bonded alkoxy group when all other conditions are the same. Furthermore, even the same type of curable group can have different reactivities depending on the number of those curable groups bonded to a particular silicon atom. For example, if a polydiorganosiloxane has three silicon-bonded alkoxy groups bonded to one silicon atom on a chain end, then the first alkoxy group is generally most reactive (reacts most quickly), but after the first alkoxy group reacts, it takes a longer time for the second alkoxy group bonded to the same silicon atom to react, and even longer for the third. Therefore, there is a continuing need to prepare clustered functional polyorganosiloxanes having more of the "most" reactive groups per molecular terminus.

[0004] Furthermore, to show utility for certain applications, such as silicone adhesive applications, a filler may be added to the composition to improve the physical property profile (e.g., increase tensile strength and increase % elongation to break) of the resulting cured product of the composition. The nature of the filler, its chemistry, particle size and surface chemistry have all been shown to influence the magnitude of the interaction between polyorganosiloxanes and the filler and consequently the ultimate physical properties. Other properties such as adhesion and dispensability also play a role in the performance and commercial acceptance of a composition for these silicone adhesive applications. Silicone adhesives generally have tensile properties in excess of 200 pounds per square inch (psi) and 100% elongation, with adhesion to a wide variety of metal, mineral and plastic surfaces.

[0005] The synthesis of 'dumb-bell' silicone polymers, in which long polymer chains are capped with cyclic, linear and star-shaped species having one or more organo-functional groups has been disclosed. Such polymers have been described which can undergo a number of cure chemistries, e.g., epoxy (glycidyl, alkylepoxy, and cycloaliphatic epoxy), methacrylate, acrylate, urethanes, alkoxy, or addition.

[0006] It is desirable to make multifunctional end blocked polymers (clustered functional polyorganosiloxanes) in which the curable groups are clustered at the ends/termini of the polymers. The combination of clustered functional groups with nonfunctional polymer chains separating them in the 'dumb-bell' silicone polymers may provide higher physical properties with the minimum drop in cure rate. This approach has been demonstrated for 'dumb-bell' silicone polymers in which the curable groups are the same (for example, all curable groups clustered at the polymer chain ends may be either epoxy or alkoxy). This approach has also been demonstrated for so called 'multiple cure' systems in which the curable groups differ, for example, all curable groups clustered at the polymer terminals may be a combination of epoxy and alkoxy groups.

[0007] Thermally conductive silicone compositions including these clustered functional polyorganosiloxanes are utilized in bonding hybrid circuit substrates, power semiconductor components and devices to heat sinks as well as for use in other bonding applications where flexibility and thermal conductivity are major concerns. The low viscosity versions of these thermally conductive silicone compositions are ideal for use as thermally conductive potting materials for transformers, power supplies, coils and other electronic devices that require improved thermal dissipation.

[0008] In order to make these curable polyorganosiloxane compositions more dispensable for application purposes, it is often necessary or desirable to reduce their viscosities through the use of viscosity reducing polymers, sometimes referred to as reactive diluents. Such reactive diluents should be compatible with the curable polyorganosiloxane compositions and function to reduce viscosity without adversely affecting properties of the composition both prior to application (such as storage stability) and subsequent to application (including curing rates and cured physical properties of the compositions). BRIEF SUMMARY OF THE INVENTION

[0009] The present invention discloses a curable silicone composition that comprises (I) a clustered functional polyorganopolysiloxane having at least one radical curable group selected from an acrylate group and a methacrylate group; (II) a silicone reactive diluent, and a (III) a radical initiator.

[0010] In certain embodiments, the clustered functional polyorganosiloxane (I) comprises a reaction product of a reaction of:

a) a polyorganosiloxane having an average of at least 2 aliphatically unsaturated organic groups per molecule;

b) a polyorganohydrogensiloxane having an average of 4 to 15 silicon atoms per molecule; and

c) a reactive species having, per molecule, at least one aliphatically unsaturated organic group and one or more radical curable groups selected from acrylate groups and methacrylate groups;

in the presence of d) a hydrosilylation catalyst and e) an isomer reducing agent.

[0011] In certain embodiments, the silicone reactive diluent (II) comprises a reaction product of a reaction of a) a polyorganohydrogensiloxane having an average of greater than 0 to 402, alternatively 10 to 200, silicon atoms per molecule; and b) a reactive species having, per molecule, at least 1 aliphatically unsaturated organic group and 1 or more curable groups; in the presence of c) an isomer reducing agent and d) a hydrosilylation catalyst and optionally e) an inhibitor for the hydrosilylation catalyst.

[0012] In certain other embodiments, the silicone reactive diluent (II) comprises a reaction product of a reaction of a) a second polyorganohydrogensiloxane of the formula HR₂SiO-

(R₂SiO)_a-SiR₂H, where each R is independently a monovalent hydrocarbon group and wherein the subscript a has an average value ranging from 0 to 400; and b) a reactive species having, per molecule, at least 1 aliphatically unsaturated organic group and 1 or more curable groups; in the presence of c) an isomer reducing agent and d) a hydrosilylation catalyst and optionally e) an inhibitor for the hydrosilylation catalyst.

[0013] In certain other embodiments, the silicone reactive diluent (II) comprises a reaction product of a reaction of: a) a siloxane compound according to the formula:

wherein:

each R is independently a monovalent hydrocarbon having 1 to 6 carbon atoms,

R' is a monovalent hydrocarbon having 3 to 12 carbon atoms.

R" is H or CH 3 ,' and

the subscripts m and n each independently have a value from 1 to 10, and

b) a polyorganosiloxane having an average, per molecule, of at least 2 aliphatically unsaturated organic groups,

in the presence of c) a first hydrosilylation catalyst and optionally d) an inhibitor for the first hydrosilylation catalyst, as well as other additional optional components.

[0014] The curable silicone composition offers many advantages due to its ability to cure by two distinct methods, namely moisture cure and thermal radical cure, without adversely affecting its mechanical and physical properties. Thus, the stable thermal radical curable silicone composition may be used over a wider variety of substrates, including plastic substrates and metal substrates, and in a wide variety of application, such as in electronics applications.

[0015] Moreover, the incorporation of silicone reactive diluents into the curable silicone compositions functions in amounts provided below functions to reduce the viscosity of the resultant compositions, but without a reduction in the cure of the applied and cured compositions, as compared curable silicone compositions having non-reactive diluents or lower levels of other types of reactive diluents.

DETAILED DESCRIPTION OF THE INVENTION

[0016] The articles 'a', 'an', and 'the' each refer to one or more, unless otherwise indicated. All amounts, ratios, and percentages in this application are by weight, unless otherwise indicated. All kinematic viscosities were measured at 25 ^QC, unless otherwise indicated. [0017] The present invention discloses a curable silicone composition that comprises (I) a clustered functional polyorganopolysiloxane having at least one radical curable group selected from an acrylate group and a methacrylate group; (II) a silicone reactive diluent, and a (III) a radical initiator, as well as other optional components.

[0018] Component (I) is a clustered functional polyorganopolysiloxane comprises a reaction product of a reaction of:

a) a polyorganosiloxane having an average, per molecule, of at least 2 aliphatically unsaturated organic groups;

c) a reactive species having, per molecule, at least 1 aliphatically unsaturated organic group and 1 or more curable groups;

in the presence of d) a hydrosilylation catalyst; and e) an isomer reducing agent; and

optional additional components.

[0019] The weight ratio of silicon bonded hydrogen atoms in component b) divided by the weight ratio of aliphatically unsaturated organic groups in component a) (the SiH^/Vig ratio) ranges from 4/1 to 20/1 .

[0020] The process for forming the clustered functional polyorganopolysiloxane (I), according to a first embodiment, may comprise:

1 ) concurrently reacting components comprising

a) a polyorganosiloxane having an average, per molecule, of at least 2 aliphatically unsaturated organic groups,

b) a polyorganohydrogensiloxane having an average, per molecule, of 4 to 15 Si atoms and at least 4 silicon bonded hydrogen atoms per aliphatically unsaturated organic group in component a), and

c) a reactive species having, per molecule, at least 1 aliphatically unsaturated organic group and 1 or more radical curable groups selected from acrylate groups and methacrylate groups;

[0021] In this process of the first embodiment, the components in step 1 ) may further comprise f) a filler, g) a non-reactive silicone resin, or a combination thereof. The processes of the first embodiment described above may optionally further comprise the steps of: 2) adding a catalyst inhibitor to deactivate the catalyst after step 1 ), and 3) purifying the product of step 2).

[0022] Alternatively, the process for forming the clustered functional polyorganopolysiloxane (I), according to a second embodiment, may comprise:

A) concurrently reacting components comprising

a) the polyorganosiloxane having an average, per molecule, of at least 2 aliphatically unsaturated organic groups; and

b) the polyorganohydrogensiloxane having an average, per molecule, of 4 to 15 Si atoms and at least 4 silicon bonded hydrogen atoms per aliphatically unsaturated organic group in component a),

in the presence of d) the hydrosilylation catalyst; and thereafter

B) reacting the product of step A) with an component comprising:

c) the reactive species having, per molecule, at least 1 aliphatically unsaturated organic group and one or more radical curable groups selected from acrylate groups and methacrylate groups;

in the presence of e) an isomer reducing agent;

with the proviso that the components in step A) and/or step B) further comprise f) a filler, g) a non-reactive silicone resin, or a combination thereof; and with the proviso that no intermediate purification step is performed between step A) and step B), and with the proviso that the SiH^/Vig ratio ranges from 4/1 to 20/1 , and a product prepared by the process has, on average, more than one curable group at each terminus of the polyorganosiloxane of component a).

[0023] The process of the second embodiment may optionally further comprise the steps of: C) adding a catalyst inhibitor to deactivate the catalyst after step B), and D) purifying the product of step C). The step of purifying the products in the above processes may be performed by any convenient means, such as stripping or distillation, optionally under vacuum.

[0024] In certain embodiments, the clustered functional organopolysiloxane (I) comprises from 20 to 80 weight percent, such as from 30 to 60 weight percent, of the total silicone matrix weight of the curable silicone composition. [0025] Component a) is a polyorganosiloxane having an average, per molecule, of at least 2 aliphatically unsaturated organic groups, which are capable of undergoing a hydrosilylation reaction with a silicon bonded hydrogen atom of component b). Component a) may have a linear or branched structure. Alternatively, component a) may have a linear structure. Component a) may be a combination comprising two or more polyorganosiloxanes that differ in at least one of the following properties: structure, viscosity, degree of polymerization, and sequence.

[0026] Component a) has a minimum average degree of polymerization (average DP) of 100. Alternatively, average DP of component a) may range from 100 to 1000. The distribution DP of polyorganosiloxanes of component a) can be bimodal. For example, component a) may comprise one alkenyl terminated polydiorganosiloxane with a DP of 60 and another alkenyl terminated polydiorganosiloxane with a DP higher than 100, provided that average DP of the polydiorganosiloxanes ranges from 100 to 1000. However, suitable polyorganosiloxanes for use in component a) have a minimum degree of polymerization (DP) of 10, provided that polyorganosiloxanes with DP less than 10 are combined with polyorganosiloxanes having DP greater than 100. Suitable polydiorganosiloxanes for component a) are known in the art and are commercially available. For example, Dow

Corning^® SFD-128 has DP ranging from 800 to 1000, Dow Corning^® SFD-120 has DP ranging from 600 to 700, Dow Corning^® 7038 has DP of 100, and Dow Corning^® SFD-1 19 has DP of 150. All of these are vinyl-terminated polydimethylsiloxanes are commercially available from Dow Corning Corporation of Midland, Michigan, USA. When component a) has a bimodal distribution, the polyorganosiloxane with the lower DP (low DP polyorganosiloxane) is present in a lower amount than the polyorganosiloxane with the higher DP (high DP polyorganosiloxane). For example, in a bimodal distribution, the ratio of low DP polyorganosiloxane/high DP polyorganosiloxane may range from 10/90 to 25/75.

[0027] Component a) is exemplified by polyorganosiloxanes of formula (I), formula (II), or a combination thereof. Formula (I) is R⁷ ₂R⁸SiO(R¹2SiO)g(R⁷R⁸SiO)hSiR⁷ ₂R⁸, and formula

(II) is R⁷ ₃SiO(R⁷ ₂SiO)j(R⁷R⁸SiO)jSiR⁷3. In these formulae, each R⁷ is independently a monovalent organic group free of aliphatic unsaturation, each R⁸ is independently an aliphatically unsaturated organic group, subscript g has an average value ranging from 2 to 1000, subscript h has an average value ranging from 0 to 1000, subscript i has an average value ranging from 0 to 1000, and subscript j has an average value ranging from 4 to 1000. In formulae (I) and (II), 10 < (g + h) <1000 and 10 < (i + j) < 1000.

[0028] Suitable monovalent organic groups for R⁷ include, but are not limited to, monovalent hydrocarbon groups exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, octyl, undecyl, and octadecyl; cycloalkyl such as cyclohexyl; and aryl such as phenyl, tolyl, xylyl, benzyl, and 2-phenylethyl. Each R⁸ is independently an aliphatically unsaturated monovalent organic group. R⁸ may be an aliphatically unsaturated monovalent hydrocarbon group exemplified by alkenyl groups such as vinyl, allyl, propenyl, and butenyl; and alkynyl groups such as ethynyl and propynyl.

[0029] Component a) may comprise a polydiorganosiloxane such as i) dimethylvinylsiloxy- terminated polydimethylsiloxane, ii) dimethylvinylsiloxy-terminated poly(dimethylsiloxane/methylvinylsiloxane), iii) dimethylvinylsiloxy-terminated polymethylvinylsiloxane, iv) trimethylsiloxy-terminated poly(dimethylsiloxane/methylvinylsiloxane), v) trimethylsiloxy-terminated polymethylvinylsiloxane, vi) dimethylvinylsiloxy-terminated poly(dimethylsiloxane/methylphenylsiloxane), vii) dimethylvinylsiloxy-terminated poly(dimethylsiloxane/diphenylsiloxane), viii) phenyl, methyl,vinyl-siloxy-terminated polydimethylsiloxane, ix) dimethylhexenylsiloxy-terminated polydimethylsiloxane, x) dimethylhexenylsiloxy-terminated poly(dimethylsiloxane/methylhexenylsiloxane), xi) dimethylhexenylsiloxy-terminated polymethylhexenylsiloxane, xii) trimethylsiloxy-terminated poly(dimethylsiloxane/methylhexenylsiloxane), or xiii) a combination thereof.

[0030] Component b) is a polyorganohydrogensiloxane having an average of 4 to 15 silicon atoms per molecule. Component b) has an average of at least 4 silicon bonded hydrogen atoms per aliphatically unsaturated organic group in component a). Component b) may be cyclic, branched, or linear. Alternatively, component b) may be cyclic. Component b) may be a combination comprising two or more polyorganohydrogensiloxanes that differ in at least one of the following properties: structure, viscosity, degree of polymerization, and sequence.

[0031] Component b) may be a cyclic polyorganohydrogensiloxane having an average of 4 to 15 siloxane units per molecule. The cyclic polyorganohydrogensiloxane may have formula (III), where formula (III) is (R⁹2Si02/2)k(HR⁹Si02/2)|_> ⁱⁿ which each R⁹ is independently a monovalent organic group free of aliphatic unsaturation, subscript k has an average value ranging from 0 to 10, subscript I has an average value ranging from 4 to 15, and a quantity (k + I) has a value ranging from 4 to 15, alternatively 4 to 12, alternatively 4 to

10, alternatively 4 to 6, and alternatively 5 to 6. Monovalent organic groups suitable for R⁹ include, but are not limited to, monovalent hydrocarbon groups exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, octyl, undecyl, and octadecyl; cycloalkyi such as cyclohexyl; and aryl such as phenyl, tolyl, xylyl, benzyl, and 2-phenylethyl.

[0032] Alternatively, component b) may be a branched polyorganohydrogensiloxane. The branched polyorganohydrogensiloxane for component b) may have formula (IV), where formula (IV) is Si-(OSiR 02)m(OSiHRl O)_m'(OSiR 0₃)_n(OSiR 02H)(4_-n), in which each R10 is independently a monovalent organic group free of aliphatic unsaturation, subscript m has a value ranging from 0 to 10, subscript m' has a value ranging from 0 to 10, and subscript n has a value ranging from 0 to 1 .

[0033] Alternatively, subscript m may be 0. When subscript m' is 0, then subscript n is also

0. Monovalent organic groups suitable for R^{1 0} include, but are not limited to, monovalent hydrocarbon groups exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, octyl, undecyl, and octadecyl; cycloalkyi such as cyclohexyl; and aryl such as phenyl, tolyl, xylyl, benzyl, and 2-phenylethyl.

[0034] Alternatively, component b) may be a linear polyorganohydrogensiloxane having an average of at least 4 silicon bonded hydrogen atoms per molecule. The linear polyorganohydrogensiloxane for component b) may have a formula selected from (V), (VI), or a combination thereof, where formula (V) is R^{1 1}2HSiO(R^{1 1}2SiO)₀(R^{1 1} HSiO)pSiR^{1 1} ₂H, formula (VI) is R^{1 1} ₃SiO(R^{1 1}2SiO)_q(R^{1 1} HSiO)_rSiR^{1 1}3; where each R^{1 1} is independently a monovalent organic group free of aliphatic unsaturation, subscript o has an average value ranging from 0 to 12, subscript p has an average value ranging from 2 to 12, subscript q has an average value ranging from 0 to 12, and subscript r has an average value ranging from 4 to 12 where 4 < (o + p) < 13 and 4 < (q + r) < 13. Monovalent organic groups suitable for

R^{1 1} include, but are not limited to, monovalent hydrocarbon groups exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, octyl, undecyl, and octadecyl; cycloalkyi such as cyclohexyl; and aryl such as phenyl, tolyl, xylyl, benzyl, and 2-phenylethyl.

[0035] Component a) and component b) may be present in amounts sufficient to provide a weight percent of silicon bonded hydrogen atoms in component b)/weight percent of unsaturated organic groups in component a) (commonly referred to as SiH_D/Vi_a ratio) ranging from 4/1 to 20/1 , alternatively 4/1 to 10/1 , and alternatively 5/1 to 20/1 . Without wishing to be bound by theory, it is thought that if SiH^/Via ratio is 30/1 or higher, the components may crosslink to form a product with undesirable physical properties; and if SiH^/Via ratio is less than 4/1 , the product of the process may not have sufficient clustered functional groups to have fast enough cure speed, particularly if a monofunctional reactive species (having one curable group per molecule) is used as component c).

[0036] Without wishing to be bound by theory, it is thought that using an excess of silicon bonded hydrogen atoms in component b), relative to aliphatically unsaturated organic groups in component a), may reduce the possibilities of producing high homologs of the clustered functional polyorganosiloxanes, which tend to be insoluble in, and may reduce storage life of, a curable silicone composition containing the clustered functional polyorganosiloxane prepared by the process described herein. The excess of silicon bonded hydrogen atoms in component b) may also result in small (relatively low DP) clustered functional polyorganosiloxanes, which may act as reactive diluents or viscosity modifiers and adhesion promoters. It is difficult to make these highly functional small molecules in an industrial environment because the inhibiting nature of small highly functional silicone hydrides means temperatures above 50^QC are typically required to initiate the hydrosilylation process. This is then followed by a large exotherm, which can be dangerous in the presence of large volumes of solvent, or if careful monitoring of reagents is not used to control the temperature. By simply changing the SiH^/Via ratio, these species can be made in a dilute solution of clustered functional polyorganosiloxane and filler, thereby significantly reducing gelation and chance of fire due to uncontrolled exothermic reaction.

[0037] Component c) is a reactive species. The reactive species may be any species that can provide the curable groups in the clustered functional polyorganosiloxane. The reactive species has an average, per molecule, of at least one aliphatically unsaturated organic group that is capable of undergoing an addition reaction with a silicon bonded hydrogen atom of component b). Component c) further comprises one or more radical curable groups per molecule. The radical curable groups are functional (reactive) groups that render the clustered functional polyorganosiloxane (prepared by the process described above) radiation curable. The radical curable groups on component c) may be selected from acrylate groups and methacrylate groups and combinations thereof. Alternatively, the curable groups on component c) may be selected from acrylate, alkoxy, epoxy, methacrylate, and combinations thereof.

[0038] For example, component c) may comprise a silane of formula (VIII), where formula (VIII) is R^{1 2}sSiR¹³(3-s); ⁱⁿ which subscript s has a value ranging from 1 to 3, each R¹² is independently an aliphatically unsaturated organic group, and each R¹³ is independently selected from an organic group containing an acrylate group and a methacrylate group.

[0039] Alternatively, component c) may comprise an organic compound (which does not contain a silicon atom). The organic compound for component c) may have an average per molecule of 1 to 2 aliphatically unsaturated organic groups, such as alkenyl or alkynyl groups, and one or more reactive groups selected from an acrylate group and a methacrylate group. Examples of suitable organic compounds for component c) include, but are not limited to, an allyl acrylate and ally I methacrylate (AMA); and combinations thereof.

[0040] The amount of component c) depends on various factors including the type, amount, and Si-H content of component b) and the type of component c) selected. However, the amount of component c) is sufficient to make 3ϊΗ¾₀¾Λ ϊ(₀¾ range from 1 /1 to 1 /1 .4, alternatively 1 /1 .2 to 1 .1 /1 . The ratio 3ϊΗ¾₀¾/νϊ¾₀¾ means the weight percent of silicon bonded hydrogen atoms on component b) and, if present component g) the chain extender and/or component h) the endcapper (described below), divided by the weight percent of aliphatically unsaturated organic groups on components a) and c) combined.

[0041] Component d) is a hydrosilylation catalyst which accelerates the reaction of components a), b), and c). Component d) may be added in an amount sufficient to promote the reaction of components a), b), and c), and this amount may be, for example, sufficient to provide 0.1 parts per million (ppm) to 1000 ppm of platinum group metal, alternatively 1 ppm to 500 ppm, alternatively 2 ppm to 200, alternatively 5 ppm to 150 ppm, based on the combined weight of all components used in the process.

[0042] Suitable hydrosilylation catalysts are known in the art and commercially available. Component d) may comprise a platinum group metal selected from platinum (Pt), rhodium, ruthenium, palladium, osmium or iridium metal or organometallic compound thereof, or a combination thereof. Component d) is exemplified by compounds such as chloroplatinic acid, chloroplatinic acid hexahydrate, platinum dichloride, and complexes of said compounds with low molecular weight organopolysiloxanes or platinum compounds microencapsulated in a matrix or coreshell type structure. Complexes of platinum with low molecular weight organopolysiloxanes include 1 ,3-diethenyl-1 ,1 ,3,3 -tetramethyldisiloxane complexes with platinum. These complexes may be microencapsulated in a resin matrix. Alternatively, the catalyst may comprise 1 ,3-diethenyl-1 ,1 ,3,3 -tetramethyldisiloxane complex with platinum. When the catalyst is a platinum complex with a low molecular weight organopolysiloxane, the amount of catalyst may range from 0.04 % to 0.4 % based on the combined weight of the components used in the process.

[0043] Suitable hydrosilylation catalysts for component d) are described in, for example, U.S. Patents 3,159,601 ; 3,220,972; 3,296,291 ; 3,419,593; 3,516,946; 3,814,730; 3,989,668; 4,784,879; 5,036,1 17; and 5,175,325 and EP 0 347 895 B. Microencapsulated hydrosilylation catalysts and methods of preparing them are known in the art, as exemplified in U.S. Patent No. 4,766,176; and U.S. Patent No. 5,017,654.

[0044] Component e) is an isomer reducing agent. In certain embodiments, the isomer reducing agent comprises a carboxylic acid compound. The carboxylic acid compound may comprise (1 ) carboxylic acid, (2) an anhydride of a carboxylic acid, (3) a carboxylic silyl ester, and/or (4) a substance that will produce the above-mentioned carboxylic acid compounds (i.e., (1 ), (2), and/or (3)) through a reaction or decomposition in the reaction of the method. It is to be appreciated that a mixture of one or more of these carboxylic acid compounds may be utilized as the isomer reducing agent. For example, a carboxylic silyl ester may be utilized in combination with an anhydride of a carboxylic acid as the isomer reducing agent. In addition, a mixture within one or more types of carboxylic acid compounds may be utilized as the isomer reducing agent. For example, two different carboxylic silyl esters may be utilized in concert, or two carboxylic silyl esters may be utilized in concert with an anhydride of a carboxylic acid.

[0045] When the isomer reducing agent comprises (1 ) carboxylic acid, any carboxylic acid having carboxyl groups may be utilized. Suitable examples of carboxylic acids include saturated carboxylic acids, unsaturated carboxylic acids, monocarboxylic acids, and dicarboxylic acids. A saturated or unsaturated aliphatic hydrocarbon group, aromatic hydrocarbon group, halogenated hydrocarbon group, hydrogen atom, or the like is usually selected as the portion other than the carboxyl groups in these carboxylic acids. Specific examples of suitable carboxylic acids include saturated monocarboxylic acids such as formic acid, acetic acid, propionic acid, n-butyric acid, isobutyric acid, hexanoic acid, cyclohexanoic acid, lauric acid, and stearic acid; saturated dicarboxylic acids such as oxalic acid and adipic acid; aromatic carboxylic acids such as benzoic acid and para-phthalic acid; carboxylic acids in which the hydrogen atoms of the hydrocarbon groups of these carboxylic acids have been substituted with a halogen atom or an organosilyl group, such as chloroacetic acid, dichloroacetic acid, trifluoroacetic acid, para-chlorobenzoic acid, and trimethylsilylacetic acid; unsaturated fatty acids such as acrylic acid, methacrylic acid, and oleic acid; and compounds having hydroxy groups, carbonyl groups, or amino groups in addition to carboxyl groups, namely, hydroxy acids such as lactic acid, keto acids such as acetoacetic acid, aldehyde acids such as glyoxylic acid, and amino acids such as glutamic acid.

[0046] When the isomer reducing agent comprises (2) an anhydride of carboxylic acid, suitable examples of anhydrides of carboxylic acids include acetic anhydride, propionic anhydride, and benzoic anhydride. These anhydrides of carboxylic acids may be obtained via a reaction or decomposition in the reaction system include acetyl chloride, butyryl chloride, benzoyl chloride, and other carboxylic acid halides, carboxylic acid metal salts such as zinc acetate and thallium acetate, and carboxylic esters that are decomposed by light or heat, such as (2-nitrobenzyl) propionate.

[0047] In embodiments where the isomer reducing agent comprises (3) a carboxylic silyl ester, suitable examples of carboxylic silyl esters are trialkylsilylated carboxylic acids, such as trimethylsilyl formate, trimethylsilyl acetate, triethylsilyl propionate, trimethylsilyl benzoate, and trimethylsilyl trifluoroacetate; and di-, tri-, or tetracarboxysilylates, such as dimethyldiacetoxysilane, diphenyldiacetoxysilane, methyltriacetoxysilane, ethyltriacetoxysilane, vinyltriacetoxysilane, di-t-butoxydiacetoxysilane, and silicon tetrabenzoate.

[0048] The isomer reducing agent is typically utilized in an amount ranging from 0.001 to 1 weight percent, alternatively from 0.01 to 0.1 weight percent, based on the total weight of the clustered functional polyorganosiloxane (I). Examples of commercially available carboxylic

®

silyl esters suitable as the isomer reducing agent are DOW CORNING ETS 900 or

XIAMETER OFS-1579 Silane, available from Dow Corning Corporation of Midland, Ml.

[0049] The isomer reducing agent e), added in a sufficient amount such as from 0.001 to 1 weight percent as noted above, promotes the alpha-addition of the Si-H groups of the polyorganosiloxane (ii) to the aliphatically unsaturated group of the reactive species c) over the beta-addition of the Si-H groups of the polyorganosiloxane (ii) to the aliphatically unsaturated group of the reactive species c). The beta-position addition may result in the subsequent further reaction of the polyorganosiloxane to generate Si-OH and associated silicon hydroxide product (sometimes referred to as D(Oz) and/or T(Oz) units). Without being bound by any theory, it is believed that the generation of Si-OH hastens moisture cure of the polyorganosiloxanes. The relative amount of D(Oz) units generated, which correlate to the amount of beta-position addition of Si-H groups of the polyorganosiloxane (ii) to the aliphatically unsaturated group of the reactive species c), may be measured by NMR.

[0050] The clustered functional polyorganosiloxane (I) produced in accordance with the present invention utilizing a sufficient amount of isomer reducing agent e) results in a reduction, and in certain embodiments at least a 10% reduction, in the amount of D(Oz) units present in the formed clustered polyorganosiloxane, as measured by NMR, which corresponds to a reduction, and in certain embodiments at least a 10% reduction in the beta- addition of Si-H groups of the polyorganosiloxane (ii) to the aliphatically unsaturated group of the reactive species c).

[0051 ] The components used in the process described above for forming the clustered functional polyorganosiloxane (I) may optionally further comprise one or more additional components selected from f) a filler, g) a non-reactive resin, h) a chain extender, and i) an endcapper, or a combination thereof. Alternatively, the components used in the process may be components a), b), c) d), e) and f). Alternatively, the components used in the process may be components a), b), c) d), e), f) and h). Alternatively, the components used in the process may be components a), b), c) d), e), f) and i). Alternatively, the components used in the process may be components a), b), c) d), e), f), h) and i).

[0052] A filler may be added during the process described above. Fillers are exemplified by reinforcing and/or extending fillers such as, alumina, calcium carbonate (e.g., fumed, ground, and/or precipitated), diatomaceous earth, quartz, silica (e.g., fumed, ground, and/or

®

precipitated), talc, zinc oxide, chopped fiber such as chopped KEVLAR , or a combination thereof. The amount of filler will depend on various factors including the type of filler selected and the end use of the clustered functional polyorganosiloxane to be produced by the process. However, the amount of filler may be up to 20 %, alternatively 1 % to 20 %, based on the combined weight of all the components. When the clustered functional polyorganosiloxane prepared by the process described above will be used in a curable silicone composition, the amount of filler may range from 10 % to 20 %. Alternatively, when the clustered functional polyorganosiloxane will be used in a sealant composition, the amount of filler may range from 4 % to 10 %. [0053] Without wishing to be bound by theory, it is thought that when the filler is added during the process described herein, this will provide an improvement in tensile properties as compared to a prior art process in which a conventional 'dumb-bell' type polyorganosiloxane is formed in a multiple step process, and thereafter a filler is dispersed. Therefore, the process according to the first embodiment described herein may further comprise: mixing component f), a filler, with component a) before or during step A) of the process described above at paragraph [0019]. Alternatively, the process of the second embodiment may further comprise mixing f) a filler with component a) before or during step A) or mixing f) a filler with the components after step I) and before or during step B) of the process described above in paragraph [0021 ].

[0054] The above process step of adding a filler may provide a benefit with many curable groups, however, adverse reactions with clustered functional polyorganosiloxanes (for example, containing hydrolyzable groups) may still be problematic. To combat this problem, the process of the first embodiment may further comprise: mixing f) a filler and f) a filler treating agent with component a) before or during step A) of the process described above at paragraph [0019]. Alternatively, the process of the second embodiment may further comprise mixing f) a filler and f) a filler treating agent with component a) before or during step A) or mixing f) a filler and f) a filler treating agent with the components after step A) and before or during step B) of the process described above in paragraph [0021 ]. The effective treatment of filler surfaces in situ as described above may require elevated temperature and/or vacuum conditions. These conditions may also be undesirable with thermally sensitive unsaturated functional groups and their oxygen enabled antioxidants. Therefore, the filler may be pretreated with the filler treating agent in the presence of component a) at elevated temperature and/or under vacuum. These filler treating conditions may be performed in a batch or continuous process as described, for example, in U.S. Patent 6,013,701 to Kunimatsu, et al.

[0055] The resulting combination of treated filler in polyorganosiloxane is referred to as a masterbatch. Masterbatches are commercially available. The use of masterbatches allows the smooth reaction of the aliphatically unsaturated organic groups of component a) with the silicon bonded hydrogen atoms of component b) and unsaturated organic groups of component c) to be performed in a single, low shear step; leading to filled clustered functional polyorganosiloxanes with superior tensile and adhesive properties along with improved rheological and storage properties. [0056] A masterbatch comprising a polyorganosiloxane having aliphatically unsaturated organic groups and a treated filler, with optionally a second polyorganosiloxane (having aliphatically unsaturated organic groups) of the same or differing molecular weight may be combined with components b) and c), and the resulting mixture may be sheared before addition of component d) at room temperature (RT). Reaction may then be initiated by raising the temperature to 50^QC to 100^QC, alternatively 70^QC to 85^QC, and maintaining the temperature until all of the Si-H has reacted, as measured by the time needed for the Si-H peak as observed by Fourier Transform Infra Red spectroscopy (FT-IR) at about 2170cm^-1 , to be reduced into the background of the spectra.

[0057] Due to the thermal stability of the aliphatically unsaturated polyorganosiloxanes and filler treating agents, these processes can be carried out at higher temperatures and shear, yielding stable, reproducible masterbatches of treated filler (such as silica) in aliphatically unsaturated polyorganosiloxane (polymer) such as vinyl endblocked PDMS. Not wanting to be constrained by theory, it is believed that exposing the polymer/filler interface to high temperature and shear, optimizes polymer/filler interactions and produces stable masterbatches. By using a masterbatch, one skilled in the art can formulate a curable silicone composition at low temperature and shear, which provides the benefit of making the process more widely applicable to prepare curable silicone compositions with different cure chemistries.

[0058] The filler treating agent may be a treating agent, which is known in the art. The amount of filler treating agent may vary depending on various factors including the type and amounts of fillers selected for component f) whether the filler is treated with filler treating agent in situ or pretreated before being combined with component a). However, the components may comprise an amount ranging from 0.1 % to 2 % of filler treating agent, based on the weight of the filler for component f).

[0059] The filler treating agent may comprise a silane such as an alkoxysilane, an alkoxy- functional oligosiloxane, a cyclic polyorganosiloxane, a hydroxyl-functional oligosiloxane such as a dimethyl siloxane or methyl phenyl siloxane, a stearate, or a fatty acid. The alkoxysilane may have the formula: R^{1 4}tSi(OR^{1 5})(4-t), where subscript t is 1 , 2, or 3; alternatively t is 3. Each R^{1 4} is independently a monovalent organic group of 1 to 50 carbon atoms, such as a monovalent hydrocarbon group of 1 to 50 carbon atoms, alternatively 6 to

18 carbon atoms. Suitable monovalent hydrocarbon groups for R^{1 4} are exemplified by alkyl groups such as hexyl, octyl, dodecyl, tetradecyl, hexadecyl, and octadecyl; and aromatic groups such as benzyl, phenyl and phenylethyl. R¹⁴ can be a monovalent hydrocarbon group that is saturated or unsaturated and branched or unbranched. Alternatively, R¹⁴ can be a saturated, unbranched, monovalent hydrocarbon group. Each R^{1 5} may be a saturated hydrocarbon group of 1 to 4 carbon atoms, alternatively 1 to 2 carbon atoms.

[0060] Alkoxysilane filler treating agents are exemplified by hexyltrimethoxysilane, octyltriethoxysilane, decyltrimethoxysilane, dodecyltrimethoxysilane, tetradecyltrimethoxysilane, phenyltrimethoxysilane, phenylethyltrimethoxysilane, octadecyltrimethoxysilane, octadecyltriethoxysilane, and a combination thereof.

[0061] Alkoxy-functional oligosiloxanes can also be used as filler treating agents. Alkoxy- functional oligosiloxanes and methods for their preparation are known in the art, see for example, EP 1 101 167 A2. For example, suitable alkoxy-functional oligosiloxanes include those of the formula (R^{1 6}0)_uSi(OSiR^{1 7}2R^{1 8})(4_-u). In this formula, subscript u is 1 , 2, or 3, alternatively u is 3. Each R^{1 6} can be independently selected from saturated and unsaturated monovalent hydrocarbon groups of 1 to 10 carbon atoms. Each R^{1 7} can be a saturated or unsaturated monovalent hydrocarbon group having at least 1 1 carbon atoms. Each R^{1 8} can be an alkyl group.

[0062] Alternatively, alkoxysilanes may be used, but typically in combination with silazanes, which catalyze the less reactive alkoxysilane reaction with surface hydroxyls. Such reactions are typically performed above 100^QC with high shear with the removal of volatile by-products such as ammonia, methanol and water.

[0063] Alternatively, the filler treating agent can be any of the organosilicon compounds typically used to treat silica fillers. Examples of organosilicon compounds include, but are not limited to, organochlorosilanes such as methyltrichlorosilane, dimethyldichlorosilane, and trimethyl monochlorosilane; organosiloxanes such as hydroxy-endblocked dimethylsiloxane oligomer, hexamethyldisiloxane, and tetramethyldivinyldisiloxane; organosilazanes such as hexamethyldisilazane and hexamethylcyclotrisilazane; and organoalkoxysilanes such as methyltrimethoxysilane, C6Hi ₃Si(OCH₃)₃, C8Hi 7Si(OC2H₅)₃, C-| oH2i Si(OCH₃)₃,

C! ₂H₂₅Si(OCH₃)₃, d ₄H₂9Si(OC₂H5)₃, and C₆H₅CH₂CH₂Si(OCH₃)₃, vinyltrimethoxysilane, vinyltriethoxysilane, 3-glycidoxypropyltrimethoxysilane, and 3- methacryloxypropyltrimethoxysilane. [0064] Filler treating agents for thermally conductive fillers, such as alumina or passivated aluminum nitride, may include alkoxysilyl functional alkylmethyl polysiloxanes (e.g., partial hydrolysis condensate of R^{1 6}o^{Rl 7}pSi(OR^{1 8})(4_-0-p) or cohydrolysis condensates or mixtures), or similar materials where the hydrolyzable group may comprise silazane, acyloxy or oximo. In all of these, a group tethered to Si, such as R^{1 6} in the formula above, is a long chain unsaturated monovalent hydrocarbon or monovalent aromatic-functional hydrocarbon.

Each R^{1 7} is independently a monovalent hydrocarbon group, and each R^{1 8} is independently a monovalent hydrocarbon group of 1 to 4 carbon atoms. In the formula above, subscript o is 1 , 2, or 3 and subscript p is 0, 1 , or 2, with the proviso that a sum (o + p) is 1 , 2, or 3.

[0065] Other filler treating agents include alkenyl functional polyorganosiloxanes. Suitable alkenyl functional polyorganosiloxanes include, but are not limited to:

CH CH OCH

3 3 3

CH =CH-Si-(OSi) -OSi-OCH

2 q 3

CH CH OCH ,

3 3 3 where subscript q' has a value up to 1 ,500. Other filler treating agents include mono- endcapped alkoxy functional polydiorganosiloxanes, i.e., polydiorganosiloxanes having an alkoxy group at one end. Such filler treating agents are exemplified by the formula:

25 26₂siO(R26₂siO)_uSi(OR²⁷)_3j where subscript u has a value of 0 to 100, alternativelyl to 50, alternatively 1 to 10, and alternatively 3 to 6. Each R²⁵ is independently selected from an alkyl group, such as methyl, ethyl, propyl, butyl, hexyl, and octyl; and an alkenyl group, such as vinyl, allyl, butenyl, and hexenyl. Each R²⁶ is independently an alkyl group such as methyl, ethyl, propyl, butyl, hexyl, and octyl. Each R²⁷ is independently an alkyl group such as methyl, ethyl, propyl, and butyl. Alternatively, each R²⁵, each R²⁶, and each R²⁷ is methyl. Alternatively, each R²^ is vinyl. Alternatively, each R²^ and each R²⁷ is methyl.

[0066] Alternatively, a polyorganosiloxane capable of hydrogen bonding is useful as a treating agent. This strategy to treating surface of a filler takes advantage of multiple hydrogen bonds, either clustered or dispersed or both, as the means to tether the compatibilization moiety to the filler surface. The polyorganosiloxane capable of hydrogen bonding has an average, per molecule, of at least one silicon-bonded group capable of hydrogen bonding. The group may be selected from: an organic group having multiple hydroxyl functionalities or an organic group having at least one amino functional group. The polyorganosiloxane capable of hydrogen bonding means that hydrogen bonding is the primary mode of attachment for the polyorganosiloxane to a filler. The polyorganosiloxane may be incapable of forming covalent bonds with the filler. The polyorganosiloxane capable of hydrogen bonding may be selected from the group consisting of a saccharide-siloxane polymer, an amino-functional polyorganosiloxane, and a combination thereof. Alternatively, the polyorganosiloxane capable of hydrogen bonding may be a saccharide-siloxane polymer.

[0067] The non-reactive silicone resin g) useful herein contains monofunctional units represented by R^{1 9}3SiO-|/2 and tetrafunctional units represented by S1O4/2. R^{1 9} represents a nonfunctional monovalent organic group such as a hydrocarbon group. The silicone resin is soluble in liquid hydrocarbons such as benzene, toluene, xylene, heptane and the like or in liquid organosilicon compounds such as a low viscosity cyclic and linear polydiorganosiloxanes.

[0068] In the R^{1 9}3SiO-|/2 unit, R^{1 9} may be a monovalent hydrocarbon group containing up to 20 carbon atoms, alternatively 1 to 10 carbon atoms. Examples of suitable monovalent hydrocarbon groups for R^{1 9} include alkyl groups, such as methyl, ethyl, propyl, butyl pentyl, octyl, undecyl and octadecyl; cycloaliphatic radicals, such as cyclohexyl and cyclohexylethyl; and aryl radicals such as phenyl, tolyl, xylyl, benzyl and 2-phenylethyl. Organic groups for R¹5 are exemplified by the hydrocarbon groups above modified such that where a non- reactive substituent has replaced a hydrogen atom, for example, the nonreactive substituents may include but are not limited to halogen and cyano. Typical organic groups that can be represented by R^{1 9} include but are not limited to chloromethyl and 3,3,3- trifluoropropyl.

[0069] The molar ratio of the R^{1 9}3SiO-|/2 and S1O4/2 units in the silicone resin may range from 0.5/1 to 1 .5/1 , alternatively from 0.6/1 to 0.9/1 . These mole ratios are conveniently measured by Silicon 29 Nuclear Magnetic Spectroscopy (²⁹Si NMR). This technique is capable of quantitatively determining the concentration of R^{1 9}3SiO-|/2 ("M") and S1O4/2 ("Q") units derived from the silicone resin, in addition to the total hydroxyl content of the silicone resin.

[0070] The silicone resin may further comprise 2.0 % or less, alternatively 0.7 % or less, alternatively 0.3 % or less, of terminal units represented by the formula XS1O3/2, where X represents hydroxyl or a hydrolyzable group exemplified by alkoxy such as methoxy and ethoxy. The concentration of hydrolyzable groups present in the silicone resin can be determined using FT-IR.

[0071] The weight average molecular weight, M_w, will depend at least in part on the molecular weight of the silicone resin and the type(s) of hydrocarbon groups, represented by R^{1 5}, that are present in this component. M_w as used herein represents the molecular weight measured using gel permeation chromatography (GPC), when the peak representing the neopentamer is excluded form the measurement. The M_w of the silicone resin may range from 12,000 to 30,000 g/mole, typically 17,000 to 22,000 g/mole.

[0072] The silicone resin can be prepared by any suitable method. Silicone resins of this type have been prepared by cohydrolysis of the corresponding silanes or by silica hydrosol capping methods known in the art. The silicone resin may be prepared by the silica hydrosol capping processes of Daudt, et al., U.S. Patent 2,676,182; of Rivers-Farrell et al., U.S. Patent 4,61 1 ,042; and of Butler, U.S. Patent 4,774,310.

[0073] The intermediates used to prepare the silicone resin are typically triorganosilanes of the formula R^{1 9}3SiX', where X' represents a hydrolyzable group, and either a silane with four hydrolyzable groups such as halogen, alkoxy or hydroxyl, or an alkali metal silicate such as sodium silicate.

[0074] It is desirable that the silicon-bonded hydroxyl groups (i.e., HOR^{1 9}SiO-|/2 or

HOS1O3/2 groups) in the silicone resin be below 0.7 % based on the total weight of the silicone resin, alternatively below 0.3 %. Silicon-bonded hydroxyl groups formed during preparation of the silicone resin may be converted to trihydrocarbylsiloxy groups or a hydrolyzable group by reacting the silicone resin with a silane, disiloxane or disilazane containing the appropriate terminal group. Silanes containing hydrolyzable groups are typically added in excess of the quantity required to react with the silicon-bonded hydroxyl groups of the silicone resin. [0075] Component h) is a chain extender. The chain extender may be a polydiorganosiloxane terminated at both ends with hydrogen atoms. An exemplary chain extender may have the formula (XVII): HR²⁰2Si-(R²⁰2SiO)_v-SiR²⁰2H, where each R²⁰ is independently a monovalent hydrocarbon group exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, and hexyl; and aryl such as phenyl, tolyl, xylyl, and benzyl. Subscript v has an average value ranging from 0 to 400, alternatively 10 to 100.

[0076] Whether to use a chain extender, and the amount used when present, depends on various factors including the degree of crosslinking inherent in the system. For example, when starting with a polyorganosiloxane for component a) which has a relatively low average DP, e.g., average DP ranging from 60 to 400, then 50 mole % to 80 mole % of the Si-H content in all of the components combined may come from the chain extender, alternatively 70 mole %. When using longer vinyl endblocked polymer (average DP > 400) then lower levels are effective, e.g., 25 mole% to 50 mole% of Si-H from chain extending molecules, preferably 40 mole%.

[0077] Component i) is an endcapper. The endcapper may be a polydiorganosiloxane having one hydrogen atom per molecule. An exemplary endcapper may have the formula

is independently a monovalent hydrocarbon group exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, and hexyl; and aryl such as phenyl, tolyl, xylyl and benzyl; and subscript e has a value ranging from 0 to 10, alternatively 1 to 10, and alternatively 1 . Another exemplary endcapper may have the formula R⁶ ₃Si-(R⁶ ₂SiO)f-(HR⁶SiO)-SiR⁶ ₃. In this formula, each R⁶ is independently a monovalent hydrocarbon group exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, and hexyl; and aryl such as phenyl, tolyl, xylyl and benzyl. Subscript f has a value ranging from 0 to 10, alternatively 0.

[0078] The endcapper may provide the benefit of producing a looser network of higher tensile properties when used as a mole percentage of the available Si-H in the system. The amount of endcapper added may range from 0 to 15 %, alternatively 2 % to 15 %, and alternatively 10 %, based on the combined weight of all components used in the process.

[0079] A secondary benefit of having an endcapper in the process is initial reduction in viscosity prior to reaction, which may facilitate the reaction and reduce the tendency for gelation due to insufficient mixing and local gel formation. [0080] Alternatively, one of a chain extender or an endcapper is used; i.e., in this instance, the chain extender and the endcapper are not in combination with each other.

[0081] The endcapper may provide the benefit of producing a looser network of higher tensile properties when used as a mole percentage of the available Si-H in the system. The amount of endcapper added may range from 0 to 15 %, alternatively 2 % to 15 %, and alternatively 10 %, based on the combined weight of all components used in the process.

[0082] A secondary benefit of having a chain extender or an endcapper in the process is initial reduction in viscosity prior to reaction, which may facilitate the reaction and reduce the tendency for gelation due to insufficient mixing and local gel formation. Using a chain extender or an endcapper may be especially beneficial when using relatively high molecular weight polyorganosiloxanes for component a) (e.g., average DP greater than 400) and when a filler is present.

[0083] The weight percent of silicon bonded hydrogen atoms in the components/weight percent of unsaturated organic groups capable of undergoing hydrosilylation in the components (commonly referred to as 3ϊΗ¾₀¾/νϊ¾₀¾ ratio) may range from 1 /1 .4 to 1 /1 , alternatively 1 /1 .2 to 1 /1 .1 . In this ratio, SiH(₀t refers to the amount of silicon bonded hydrogen atoms in component b) in combination with the amount of silicon bonded hydrogen atoms in components h) and/or i), if present. Vij₀t refers to the total amount of aliphatically unsaturated organic groups in components a) and c) combined.

[0084] Component j) is a catalyst inhibitor. Component j) may optionally be added after step

I ) in the first embodiment of the process described above in paragraph [0019] or after step

II) in the second embodiment of the process described above in paragraph [0021 ] to stop the reaction and stabilize the clustered functional polyorganosiloxane prepared by the process described above. Some examples of suitable catalyst inhibitors include ethylenically or aromatically unsaturated amides, acetylenic compounds such as 2-ethynyl-isopropanol, 2- ethynyl-butane-2-ol, 2-methyl-3-butyn-2-ol, 2-phenyl-3-butyn-2-ol, 3,5-dimethyl-1 -hexyn-3-ol, 1 -ethynyl-1 -cyclohexanol, 1 ,5-hexadiene, 1 ,6-heptadiene; 3,5-dimethyl-1 -hexen-1 -yne; 3- ethyl-3-buten-1 -yne or 3-phenyl-3-buten-1 -yne; ethylenically unsaturated isocyanates; silylated acetylenic alcohols exemplified by trimethyl (3,5-dimethyl-1 -hexyn-3-oxy)silane, dimethyl-bis-(3-methyl-1 -butyn-oxy)silane, methylvinylbis(3-methyl-1 -butyn-3-oxy)silane, and ((1 ,1 -dimethyl-2-propynyl)oxy)trimethylsilane; unsaturated hydrocarbon diesters; conjugated ene-ynes exemplified by 2-isobutyl-1 -butene-3-yne, 3,5-dimethyl-3-hexene-1 -yne, 3-methyl- 3-pentene-1 -yne, 3-methyl-3-hexene-1 -yne, 1 -ethynylcyclohexene, 3-ethyl-3-butene-1 -yne, and 3-phenyl-3-butene-1 -yne; olefinic siloxanes such as 1 ,3-divinyltetramethyldisiloxane, 1 ,3,5,7-tetravinyltetramethyl cyclotetrasiloxane, or 1 ,3-divinyl-1 ,3-diphenyldimethyldisiloxane; 1 ,3,5,7-tetramethyl-1 ,3,5,7-tetravinylcyclotetrasiloxane; a mixture of a conjugated ene-yne as described above and an olefinic siloxane as described above; hydroperoxides; nitriles and diaziridines; unsaturated carboxylic esters exemplified by diallyl maleate, dimethyl maleate, diethyl fumarate, diallyl fumarate, and bis-2-methoxy-1 -methylethylmaleate, mono- octylmaleate, mono-isooctylmaleate, mono-allyl maleate, mono-methyl maleate, mono-ethyl fumarate, mono-allyl fumarate, and 2-methoxy-1 -methylethylmaleate; fumarates such as diethylfumarate; fumarate/alcohol mixtures wherein the alcohol is benzyl alcohol or 1 -octanol and ethenyl cyclohexyl-1 -ol; a nitrogen-containing compound such as tributylamine, tetramethylethylenediamine, benzotriazole; a similar phosphorus-containing compound such as triphenylphosphine; a sulphur-containing compound; a hydroperoxy compound; or a combination thereof.

[0085] The inhibitors are used in an amount effective to deactivate component d) the hydrosilylation catalyst. The amount will vary depending on the type and amount of catalyst and the type of inhibitor selected, however, the amount may range from 0.001 to 3 parts by weight, and alternatively from 0.01 to 1 part by weight per 100 parts by weight of component a).

[0086] Component (II) is a silicone reactive diluent. The silicone reactive diluent (II) aids in dispensing of the curable silicone composition by reducing the viscosity of the curable silicone composition to make it more flowable.

[0087] In certain embodiments, the amount of silicone reactive diluent (II) utilized ranges from 5 to 80 weight percent, alternatively from 40 to 70 weight percent, alternatively from 55 to 75 weight percent, based on the total silicone matrix weight of the curable silicone composition.

[0088] The silicone reactive diluent (II) may be a monofunctional silicone reactive diluent, a difunctional silicone reactive diluent, a polyfunctional silicone reactive diluent, or a combination thereof. The silicone reactive diluent selected will depend on various factors including the curable groups. However, examples of curable groups on the suitable silicone reactive diluents include an acrylate, an anhydride such as a maleic anhydride or methacrylic anhydride, an epoxy such as a monofunctional epoxy compound, a methacrylate such as glycidyl methacrylate, an oxetane, a vinyl acetate, a vinyl ester, a vinyl ether, a fluoro alkyl vinyl ether, a vinyl pyrrolidone such as N-vinyl pyrrolidone, a styrene, or a combination thereof.

[0089] A first embodiment of the silicone reactive diluent (II) may be formed as a reaction product of a reaction of:

a) a polyorganohydrogensiloxane having an average of greater than 0 to 402, alternatively 10 to 200, silicon atoms per molecule; and

b) a reactive species having, per molecule, at least 1 aliphatically unsaturated organic group and 1 or more curable groups;

in the presence of c) an isomer reducing agent and d) a hydrosilylation catalyst and e) inhibitor for hydrosilylation catalyst.

[0090] In certain other embodiments, additional optional components may also be included in the silicone reactive diluent (II) of the first embodiment.

[0091] In this first embodiment, component a) is a polyorganohydrogensiloxane having an average of greater than 0 to 402, alternatively, 10 to 200 silicon atoms per molecule. Component a) may be branched, or linear. Component a) may be monofunctional (i.e., includes one silicon-bonded hydrogen atom), a difunctional (i.e., includes two silicon-bonded hydrogen atoms), a polyfunctional (i.e., includes more than two silicon-bonded hydrogen atoms), or a combination thereof. Component a) may be a combination comprising two or more polyorganohydrogensiloxanes each having an average of of greater than 0 to 402, alternatively, 10 to 200 silicon atoms per molecule that differ in at least one of the following properties: structure, viscosity, degree of polymerization, and sequence.

[0092] Alternatively, component a) of this first embodiment may be a branched polyorganohydrogensiloxane. The branched polyorganohydrogensiloxane for component a) may have the formula Si-(OSiR²2)b(OSiHR²)b'(OSiR²3)_c(OSiR²2H)(_4-c), in which each R² is independently a monovalent organic group free of aliphatic unsaturation, subscript b has a value ranging from 0 to 10, subscript b' has a value ranging from 0 to 10, and subscript c has a value ranging from 0 to 1 .

[0093] Alternatively, subscript b may be 0. When subscript b' is 0, then subscript c is also 0.

Monovalent organic groups suitable for R² include, but are not limited to, monovalent hydrocarbon groups exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, octyl, undecyl, and octadecyl; cycloalkyl such as cyclohexyl; and aryl such as phenyl, tolyl, xylyl, benzyl, and 2-phenylethyl. [0094] In certain other embodiments, the silicone reactive diluent (II) as described above may be formed with an alternative polyorganohydrogensiloxane comprising a polydiorganosiloxane terminated at both ends with hydrogen atoms. One exemplary polydiorganosiloxane terminated at both ends with hydrogen atoms may have the formula HR₂SiO-(R₂SiO)_a-SiR₂H, where each R is independently a monovalent hydrocarbon group exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, and hexyl; and aryl such as phenyl, tolyl, xylyl, and benzyl. Subscript a has an average value ranging from 0 to 400, alternatively 10 to 200.

[0095] Component b) is a reactive species. The reactive species b) may be any species that can provide the curable groups in the silicone reactive diluent. The reactive species has an average, per molecule, of at least one aliphatically unsaturated organic group that is capable of undergoing an addition reaction with a silicon bonded hydrogen atom of component a). Component b) further comprises one or more radical curable groups per molecule. The radical curable groups are functional (reactive) groups that render the silicone reactive diluent radiation curable. The radical curable groups on component b) may be selected from acrylate groups and methacrylate groups and combinations thereof.

[0096] For example, in certain embodiments, component b) may comprise a silane of formula R³dSiR⁴(3-d); ⁱⁿ which subscript d has a value ranging from 1 to 3, each R³ is independently an aliphatically unsaturated organic group, and each R⁴ is independently selected from an organic group containing an acrylate group and a methacrylate group.

[0097] Alternatively, component b) may comprise an organic compound (which does not contain a silicon atom). The organic compound for component b) may have an average per molecule of 1 to 2 aliphatically unsaturated organic groups, such as alkenyl or alkynyl groups, and one or more reactive groups selected from an acrylate group and a methacrylate group. Examples of suitable organic compounds for component b) include, but are not limited to, allyl acrylate and allyl methacrylate (AMA), and combinations thereof.

[0098] The amount of component b) depends on various factors including the type, amount, and Si-H content of component a) and the type of component b) selected. However, the amount of component b) is sufficient to make SiH_j0t/Vi_j0t range from 1/1 to 1/1 .4, alternatively 1/1 .2 to 1 .1/1 . The ratio SiH_j0t/Vi_j0t means the weight percent of silicon bonded hydrogen atoms on component b) divided by the weight percent of aliphatically unsaturated organic groups on component a). [0099] Component c) is an isomer reducing agent. In certain embodiments, the isomer reducing agent comprises a carboxylic acid compound. The carboxylic acid compound may comprise (1 ) carboxylic acid, (2) an anhydride of a carboxylic acid, (3) a carboxylic silyl ester, and/or (4) a substance that will produce the above-mentioned carboxylic acid compounds (i.e., (1 ), (2), and/or (3)) through a reaction or decomposition in the reaction of the method. It is to be appreciated that a mixture of one or more of these carboxylic acid compounds may be utilized as the isomer reducing agent. For example, a carboxylic silyl ester may be utilized in combination with an anhydride of a carboxylic acid as the isomer reducing agent. In addition, a mixture within one or more types of carboxylic acid compounds may be utilized as the isomer reducing agent. For example, two different carboxylic silyl esters may be utilized in concert, or two carboxylic silyl esters may be utilized in concert with an anhydride of a carboxylic acid.

[00100] When the isomer reducing agent comprises (1 ) carboxylic acid, any carboxylic acid having carboxyl groups may be utilized. Suitable examples of carboxylic acids include saturated carboxylic acids, unsaturated carboxylic acids, monocarboxylic acids, and dicarboxylic acids. A saturated or unsaturated aliphatic hydrocarbon group, aromatic hydrocarbon group, halogenated hydrocarbon group, hydrogen atom, or the like is usually selected as the portion other than the carboxyl groups in these carboxylic acids. Specific examples of suitable carboxylic acids include saturated monocarboxylic acids such as formic acid, acetic acid, propionic acid, n-butyric acid, isobutyric acid, hexanoic acid, cyclohexanoic acid, lauric acid, and stearic acid; saturated dicarboxylic acids such as oxalic acid and adipic acid; aromatic carboxylic acids such as benzoic acid and para-phthalic acid; carboxylic acids in which the hydrogen atoms of the hydrocarbon groups of these carboxylic acids have been substituted with a halogen atom or an organosilyl group, such as chloroacetic acid, dichloroacetic acid, trifluoroacetic acid, para-chlorobenzoic acid, and trimethylsilylacetic acid; unsaturated fatty acids such as acrylic acid, methacrylic acid, and oleic acid; and compounds having hydroxy groups, carbonyl groups, or amino groups in addition to carboxyl groups, namely, hydroxy acids such as lactic acid, keto acids such as acetoacetic acid, aldehyde acids such as glyoxylic acid, and amino acids such as glutamic acid.

[00101] When the isomer reducing agent comprises (2) an anhydride of carboxylic acid, suitable examples of anhydrides of carboxylic acids include acetic anhydride, propionic anhydride, and benzoic anhydride. These anhydrides of carboxylic acids may be obtained via a reaction or decomposition in the reaction system include acetyl chloride, butyryl chloride, benzoyl chloride, and other carboxylic acid halides, carboxylic acid metal salts such as zinc acetate and thallium acetate, and carboxylic esters that are decomposed by light or heat, such as (2-nitrobenzyl) propionate.

[00102] In embodiments where the isomer reducing agent comprises (3) a carboxylic silyl ester, suitable examples of carboxylic silyl esters are trialkylsilylated carboxylic acids, such as trimethylsilyl formate, trimethylsilyl acetate, triethylsilyl propionate, trimethylsilyl benzoate, and trimethylsilyl trifluoroacetate; and di-, tri-, or tetracarboxysilylates, such as dimethyldiacetoxysilane, diphenyldiacetoxysilane, methyltriacetoxysilane, ethyltriacetoxysilane, vinyltriacetoxysilane, di-t-butoxydiacetoxysilane, and silicon tetrabenzoate.

[00103] The isomer reducing agent c) is typically utilized in an amount ranging from 0.001 to 1 weight percent, alternatively from 0.01 to 0.1 weight percent, based on the total weight of the formed silicone reactive diluent (II) of the first embodiment. Examples of commercially available carboxylic silyl esters suitable as the isomer reducing agent are

DOW CORNING^® ETS 900 or XIAMETER^® OFS-1579 Silane, available from Dow Corning Corporation of Midland, Ml.

[00104] The isomer reducing agent c), added in a sufficient amount such as from 0.001 to 1 weight percent as noted above, promotes the alpha-addition of the Si-H groups of the polyorganohydrogensiloxane a) of the first embodiment, or the polyorganohydrogensiloxane a) of the formula HR₂SiO-(R₂SiO)_a-SiR₂H, to the aliphatically unsaturated group of the reactive species b) over the beta-addition of the Si-H groups of the polydiorganosiloxane (a) to the aliphatically unsaturated group of the reactive species b). The beta-position addition may result in the subsequent further reaction of the polyorganosiloxane to generate Si-OH and associated silicon hydroxide product (sometimes referred to as D(Oz) and/or T(Oz) units). Without being bound by any theory, it is believed that the generation of Si-OH hastens moisture cure of the polydiorganosiloxanes. The relative amount of D(Oz) units generated, which correlate to the amount of beta-position addition of Si-H groups of the polyorganohydrogensiloxane to the aliphatically unsaturated group of the reactive species b), may be measured by NMR.

[00105] Component d) is a hydrosilylation catalyst which accelerates the reaction of components a) and b). Component d) may be added in an amount sufficient to promote the reaction of components a) and b), and this amount may be, for example, sufficient to provide 0.1 parts per million (ppm) to 1000 ppm of platinum group metal, alternatively 1 ppm to 500 ppm, alternatively 2 ppm to 200, alternatively 5 ppm to 20 ppm, based on the combined weight of all components used in the process.

[00106] Suitable hydrosilylation catalysts are known in the art and commercially available. Component d) may comprise a platinum group metal selected from platinum (Pt), rhodium, ruthenium, palladium, osmium or iridium metal or organometallic compound thereof, or a combination thereof. Component d) is exemplified by compounds such as chloroplatinic acid, chloroplatinic acid hexahydrate, platinum dichloride, and complexes of said compounds with low molecular weight organopolysiloxanes or platinum compounds microencapsulated in a matrix or coreshell type structure. Complexes of platinum with low molecular weight organopolysiloxanes include 1 ,3-diethenyl-1 ,1 ,3,3 -tetramethyldisiloxane complexes with platinum. These complexes may be microencapsulated in a resin matrix. Alternatively, the catalyst may comprise 1 ,3-diethenyl-1 ,1 ,3,3 -tetramethyldisiloxane complex with platinum. When the catalyst is a platinum complex with a low molecular weight organopolysiloxane, the amount of catalyst may range from 0.04 % to 0.4 % based on the combined weight of the components used in the process.

[00107] Suitable hydrosilylation catalysts for component d) are described in, for example, U.S. Patents 3,159,601 ; 3,220,972; 3,296,291 ; 3,419,593; 3,516,946; 3,814,730; 3,989,668; 4,784,879; 5,036,1 17; and 5,175,325 and EP 0 347 895 B. Microencapsulated hydrosilylation catalysts and methods of preparing them are known in the art, as exemplified in U.S. Patent No. 4,766,176; and U.S. Patent No. 5,017,654.

[00108] Component e) is a catalyst inhibitor, which is added to deactivate component d) (the hydrosilylation catalyst) and stabilize the formed silicone reactive diluents. Some examples of suitable catalyst inhibitors include ethylenically or aromatically unsaturated amides, acetylenic compounds such as 2-ethynyl-isopropanol, 2-ethynyl-butane-2-ol, 2- methyl-3-butyn-2-ol, 2-phenyl-3-butyn-2-ol, 3,5-dimethyl-1 -hexyn-3-ol, 1 -ethynyl-1 - cyclohexanol, 1 ,5-hexadiene, 1 ,6-heptadiene; 3,5-dimethyl-1 -hexen-1 -yne; 3-ethyl-3-buten- 1 -yne or 3-phenyl-3-buten-1 -yne; ethylenically unsaturated isocyanates; silylated acetylenic alcohols exemplified by trimethyl (3,5-dimethyl-1 -hexyn-3-oxy)silane, dimethyl-bis-(3-methyl- 1 -butyn-oxy)silane, methylvinylbis(3-methyl-1 -butyn-3-oxy)silane, and ((1 ,1 -dimethyl-2- propynyl)oxy)trimethylsilane; unsaturated hydrocarbon diesters; conjugated ene-ynes exemplified by 2-isobutyl-1 -butene-3-yne, 3,5-dimethyl-3-hexene-1 -yne, 3-methyl-3-pentene- 1 - yne, 3-methyl-3-hexene-1 -yne, 1 -ethynylcyclohexene, 3-ethyl-3-butene-1 -yne, and 3- phenyl-3-butene-1 -yne; olefinic siloxanes such as 1 ,3-divinyltetramethyldisiloxane, 1 ,3,5,7- tetravinyltetramethyl cyclotetrasiloxane, or 1 ,3-divinyl-1 ,3-diphenyldimethyldisiloxane; 1 ,3,5,7-tetramethyl-1 ,3,5,7-tetravinylcyclotetrasiloxane; a mixture of a conjugated ene-yne as described above and an olefinic siloxane as described above; hydroperoxides; nitriles and diaziridines; unsaturated carboxylic esters exemplified by diallyl maleate, dimethyl maleate, diethyl fumarate, diallyl fumarate, and bis-2-methoxy-1 -methylethylmaleate, mono- octylmaleate, mono-isooctylmaleate, mono-allyl maleate, mono-methyl maleate, mono-ethyl fumarate, mono-allyl fumarate, and 2-methoxy-1 -methylethylmaleate; fumarates such as diethylfumarate; fumarate/alcohol mixtures wherein the alcohol is benzyl alcohol or 1 -octanol and ethenyl cyclohexyl-1 -ol; a nitrogen-containing compound such as tributylamine, tetramethylethylenediamine, benzotriazole; a similar phosphorus-containing compound such as triphenylphosphine; a sulphur-containing compound; a hydroperoxy compound; or a combination thereof.

[00109] The inhibitors are used in an amount effective to deactivate component d) the hydrosilylation catalyst. The amount will vary depending on the type and amount of catalyst and the type of inhibitor selected, however, the amount may range from 0.001 to 3 parts by weight, and alternatively from 0.01 to 1 part by weight per 100 parts by weight of component a).

[00110] In addition to Components a)-e), other optional components may be utilized in forming the silicone reactive diluents. For example, in certain embodiments, the silicone reactive diluent may further include f) a polymerization inhibitor and g) an endcapper.

[00111 ] Optional component f) is a polymerization inhibitor. The unsaturated groups (e.g., methacrylate, acrylate, vinyl or allyl) can autopolymerize via unwanted radical process. These radical processes can be mitigated by the addition of polymerization inhibitors. Examples of suitable polymerization inhibitors for acrylate and methacrylate curable groups include, but are not limited to: 2,6,-Di-tert-butyl-4-(dimethylaminomethyl)phenol (DBAP), hydroquinone (HQ); 4-methoxyphenol (MEHQ) ; 4-ethoxyphenol; 4-propoxyphenol; 4- butoxyphenol; 4-heptoxyphenol; butylated hydroxytoluene (BHT); hydroquinone monobenzylether; 1 ,2-dihydroxybenzene; 2-methoxyphenol; 2,5-dichlorohydroquinone; 2,5- di-tert-butylhydroquinone; 2-acetylhydroquinone; hydroquinone monobenzoate; 1 ,4- dimercaptobenzene; 1 ,2-dimercaptobenzene; 2,3,5-trimethylhydroquinone; 4-aminophenol;

2- aminophenol; 2-N, N-dimethylaminophenol; 2-mercaptophenol; 4-mercaptophenol; catechol monobutylether; 4-ethylaminophenol; 2,3-dihydroxyacetophenone; pyrogallol-1 ,2- dimethylether; 2-methylthiophenol; t-butyl catechol; di-tert-butylnitroxide; di-tert- amylnitroxide; 2,2,6,6-tetramethyl-piperidinyloxy; 4-hydroxy-2,2,6,6-tetramethyl- piperidinyloxy; 4-oxo-2,2,6,6-tetramethyl-piperidinyloxy; 4-dimethylamino-2,2,6,6- tetramethyl-piperidinyloxy; 4-amino-2,2,6,6-tetramethyl-piperidinyloxy; 4-ethanoloxy-2,2,6,6- tetramethyl-piperidinyloxy; 2,2,5,5-tetramethyl-pyrrolidinyloxy; 3-amino-2,2,5,5-tetramethyl- pyrrolidinyloxy; 2,2,5, 5-tetramethyl-1 -oxa-3-azacyclopentyl-3-oxy; 2,2,5,5-tetramethyl-3- pyrrolinyl-1 -oxy-3-carboxylic acid; 2,2,3,3, 5, 5,6, 6-octamethyl-1 ,4-diazacyclohexyl-1 ,4-dioxy; salts of 4-nitrosophenolate; 2-nitrosophenol; 4-nitrosophenol; copper dimethyldithiocarbamate; copper diethyldithiocarbamate; copper dibutyldithiocarbamate; copper salicylate; methylene blue; iron; phenothiazine (PTZ); 3-oxophenothiazine; 5- oxophenothiazine; phenothiazine dimer; 1 ,4-benzenediamine; N-(1 ,4-dimethylpentyl)-N'- phenyl-1 ,4-benzenediamine; N-(1 ,3-dimethylbutyl)-N'-phenyl-1 ,4-benzenediamine; N- nitrosophenylhydroxylamine and salts thereof; nitric oxide; nitrobenzene; p-benzoquinone; pentaerythrityl tetrakis(3-laurylthiopropionate); dilauryl thiodipropionate; distearyll thiodipropionate; ditridecyl thiodipropionate; tetrakis[methylene 3-(3,5-di-tert-butyl-4- hydroxyphenyl)propionate]methane; thiodiethylene bis[3-(3,5-di-tert-butyl-4- hydroxyphenyl)propionate]; octadecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate; isotridecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate; N,N'-hexamethyl (3,5 -di- tertbutyl-4-hydroxyhydrocinnamamide); iso-octyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate; 2,2'-ethylidenebis-(4,6-di-tert-butylphenol); 1 ,3,5-trimethyl-2,4,6-tris(3,5-di-tert- butyl-4-hydroxybenzyl) benzene; 4,6-bis(octylthiomethyl)-o-cresol; triethylene glycol-bis-3-(3- tert-butyl-4-hydroxy-5-methylphenyl)propionate; tris-(3,5-di-tert-butylhydroxybenzyl) isocyanurate; tris(2,4-di-tert-butylphenyl) phosphate; distearyl pentaerythritol diphosphite; bis(2,4-di-tert-butyl phenyl)pentaerythritol diphosphite; 2, 5 -di-tert-amyl-hydroquinone; or isomers thereof; combinations of two or more thereof; or combinations of one or more of the above with molecular oxygen. When present, the polymerization inhibitor may be added to the curable silicone composition in an amount ranging from 100 ppm to 4,000 ppm.

[00112] Optional component g) is an endcapper. The endcapper may be a polydiorganosiloxane having one hydrogen atom per molecule. An exemplary endcapper may have the formula R^Si-iR^SiC^e-SiR^H. In this formula, each R5 is independently a monovalent hydrocarbon group exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, and hexyl; and aryl such as phenyl, tolyl, xylyl and benzyl; and subscript e has a value ranging from 0 to 10, alternatively 1 to 10, and alternatively 1 . Another exemplary endcapper may have the formula R⁶3Si-(R⁶2SiO)f-(HR⁶SiO)-SiR⁶3. In this formula, each

R⁶ is independently a monovalent hydrocarbon group exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, and hexyl; and aryl such as phenyl, tolyl, xylyl and benzyl. Subscript f has a value ranging from 0 to 10, alternatively 0.

[00113] The endcapper may provide the benefit of producing a looser network of higher tensile properties when used as a mole percentage of the available Si-H in the system. The amount of endcapper added may range from 0 to 15 %, alternatively 2 % to 15 %, and alternatively 10 %, based on the combined weight of all components used in the process.

[00114] A secondary benefit of having an endcapper in the process is initial reduction in viscosity prior to reaction, which may facilitate the reaction and reduce the tendency for gelation due to insufficient mixing and local gel formation.

[00115] The molar ratio of silicon bonded hydrogen atoms in the components/unsaturated organic groups capable of undergoing hydrosilylation in the components (commonly referred to as SiH_j0t/Vi_j0t ratio) may range from 1/1 .4 to 1/1 , alternatively 1/1 .2 to 1 /1 .1 . In this ratio, SiH₍₀t refers to the amount of silicon bonded hydrogen atoms in any of the components of the silicone reactive diluent. Vi₍₀t refers to the total amount of aliphatically unsaturated organic groups in the silicone reactive diluent.

[00116] In certain embodiments, the silicone reactive diluent in accordance with the present invention is formed by:

1 ) concurrently reacting components comprising:

a) a polyorganohydrogensiloxane having an average of 10 to 200 silicon atoms per molecule; and

in the presence of c) an isomer reducing agent and d) a hydrosilylation catalyst, and optionally f) a polymerization inhibitor and g) an endcapper.

[00117] The resulting mixture of a), b), c), d) and optionally f) and g) may be sheared before addition of component c) at room temperature. The reaction may then be initiated by raising the temperature to a range from 35^QC to 100^QC, alternatively 50^QC to 85 ^QC, and maintaining the temperature until all of the Si-H has reacted, as measured by the time needed for the Si-H peak as observed by Fourier Transform Infra Red spectroscopy (FT-IR)

-1

at about 2170cm , to be reduced into the background of the spectra.

[00118] Next, the catalyst inhibitor e) is added to the resulting mixture to deactivate the hydrosilylation catalyst c). In certain embodiments, the introduction of the catalyst inhibitor e) is done after reducing the temperature of the reaction mixture of a), b), c), d) and optionally f) and g) below the minimum reaction temperature of 50^QC, such as at room temperature. The formed silicone reactive diluent (II) of the first embodiment may be stored for subsequent use.

[00119] In an alternative or second embodiment, the silicone reactive diluent (II) may be formed as a reaction product of a reaction of:

a) a siloxane compound according to the formula:

wherein:

each R is independently a monovalent hydrocarbon having 1 to 6 carbon atoms,

R' is a monovalent hydrocarbon having 3 to 12 carbon atoms.

R" is H or CH , and

3'

the subscripts m and n each have a value from 1 to 10, and b) a polyorganosiloxane having an average, per molecule, of at least 2 aliphatically unsaturated organic groups,

in the presence of c) a first hydrosilylation catalyst and d) an inhibitor for the first hydrosilylation catalyst, as well as other additional optional components.

[00120] Component b) of the silicone reactive diluent (II) of the second embodiment is a polyorganosiloxane having an average, per molecule, of at least 2 aliphatically unsaturated organic groups, which are capable of undergoing a hydrosilylation reaction with a silicon bonded hydrogen atom of the siloxane compound a). Component b) may have a linear or branched structure. Alternatively, component b) may have a linear structure. Component b) may be a combination comprising two or more polyorganosiloxanes that differ in at least one of the following properties: structure, viscosity, degree of polymerization, and sequence.

[00121] Component b) has a minimum average degree of polymerization (average DP) of 10. Alternatively, average DP of component b) may range from 10 to 1000 alternatively 100 to 200. The distribution DP of polyorganosiloxanes of component a) can be bimodal. For example, component b) may comprise one alkenyl terminated polydiorganosiloxane with a DP of 2 and another alkenyl terminated polydiorganosiloxane with a DP higher than 10, provided that average DP of the polydiorganosiloxanes ranges from 10 to 1000. However, suitable polyorganosiloxanes for use in component b) have a minimum degree of polymerization (DP) of 10, provided that polyorganosiloxanes with DP less than 10 are combined with polyorganosiloxanes having DP greater than 10. Suitable polydiorganosiloxanes for component a) are known in the art and are commercially

®

available. For example, Dow Corning SFD-128 has DP ranging from 800 to 1000, Dow

Corning ^@ SFD-120 has DP ranging from 600 to 700, Dow Corning^® 7038 has DP of 100, and

®

Dow Corning SFD-1 19 has DP of 150. All of these are vinyl-terminated polydimethylsiloxanes are commercially available from Dow Corning Corporation of Midland, Michigan, USA. When component b) has a bimodal distribution, the polyorganosiloxane with the lower DP (low DP polyorganosiloxane) is present in a lower amount than the polyorganosiloxane with the higher DP (high DP polyorganosiloxane). For example, in a bimodal distribution, the ratio of low DP polyorganosiloxane/high DP polyorganosiloxane may range from 10/90 to 25/75.

[00122] Component b) is exemplified by polyorganosiloxanes of formula (I), formula

(II), or a combination thereof. Formula (I) is R¹2R²SiO(R¹ ₂SiO)_a(R¹ R²SiO)bSiR¹ ₂R², ^and formula (II) is R¹ ₃SiO(R¹ ₂SiO)_c(R¹ R²SiO)dSiR¹3. In these formulae, each R is independently a monovalent organic group free of aliphatic unsaturation, each R² is independently an aliphatically unsaturated organic group, subscript a has an average value ranging from 2 to 1000, subscript b has an average value ranging from 0 to 1000, subscript c has an average value ranging from 0 to 1000, and subscript d has an average value ranging from 4 to 1000. In formulae (I) and (II), 10 < (a + b) <1000 and 10 < (c + d) < 1000.

[00123] Suitable monovalent organic groups for R¹ include, but are not limited to, monovalent hydrocarbon groups exemplified by alkyl such as methyl, ethyl, propyl, butyl, pentyl, octyl, undecyl, and octadecyl; cycloalkyl such as cyclohexyl; and aryl such as phenyl, tolyl, xylyl, benzyl, and 2-phenylethyl. Each R² is independently an aliphatically unsaturated monovalent organic group. R² may be an aliphatically unsaturated monovalent hydrocarbon group exemplified by alkenyl groups such as vinyl, allyl, propenyl, and butenyl; and alkynyl groups such as ethynyl and propynyl.

[00124] Component b) may comprise a polydiorganosiloxane such as i) dimethylvinylsiloxy-terminated polydimethylsiloxane, ii) dimethylvinylsiloxy-terminated poly(dimethylsiloxane/methylvinylsiloxane), iii) dimethylvinylsiloxy-terminated polymethylvinylsiloxane, iv) trimethylsiloxy-terminated poly(dimethylsiloxane/methylvinylsiloxane), v) trimethylsiloxy-terminated polymethylvinylsiloxane, vi) dimethylvinylsiloxy-terminated poly(dimethylsiloxane/methylphenylsiloxane), vii) dimethylvinylsiloxy-terminated poly(dimethylsiloxane/diphenylsiloxane), viii) phenyl, methyl, vinyl-siloxy-terminated polydimethylsiloxane, ix) dimethylhexenylsiloxy-terminated polydimethylsiloxane, x) dimethylhexenylsiloxy-terminated poly(dimethylsiloxane/methylhexenylsiloxane), xi) dimethylhexenylsiloxy-terminated polymethylhexenylsiloxane, xii) trimethylsiloxy-terminated poly(dimethylsiloxane/methylhexenylsiloxane), or xiii) a combination thereof.

[00125] The relative amounts of the siloxane compound a) and the polyorganosiloxane b) in the silicone reactive diluent (II) of the second embodiment may vary such that the SiH:vinyl weight ratio ranges from 0.8:1 to 1 :1 .

[00126] Suitable hydrosilylation catalysts c) and inhibitors for the hydrosilylation catalyst d) that may be used in forming the silicone reactive diluent (II) in the second embodiment include each of the hydrosilylation catalysts and inhibitors d) described in paragraphs [00107]-[001 10] above and not repeated herein.

[00127] In addition to Components a)-d), other optional components may be utilized in forming the silicone reactive diluent (II) according to the second embodiment, including f) a polymerization inhibitor and g) an endcapper, the descriptions of which are the same as provided as optional components f) and g) of the silicone reactive diluent (II) of the first embodiment in paragraphs [001 10]-[001 14] above and not repeated herein.

[00128] Component (III) is a radical initiator. The radical initiator may be a thermal radical initiator. Thermal radical initiators include, but are not limited to, dicumyl peroxide, n- butyl 4,4'-bis(butylperoxy)valerate, 1 ,1 -bis(t-butylperoxy)-3,3,5 trimethyl cyclohexane, di-t- butyl peroxide and 2,5-di-(t-butylperoxy)-2,5 dimethyl hexane, 1 ,1 -bis(tert-

®

amylperoxy)cyclohexane (Luperox 531 M80); 2,2-bis(tert-butylperoxy)butane; 2,4-

®

pentanedione peroxide (Luperox 224), 2,5-bis(tert-butylperoxy)-2,5-dimethylhexane

®

(Luperox 101 ), 2,5-di(tert-butylperoxy)-2,5-dimethyl-3-hexyne; 2-butanone peroxide,

® ®

benzoyl peroxide, cumene hydroperoxide, di-tert-amyl peroxide (Luperox DTA ), lauroyl

®

peroxide (Luperox LP), tert-butyl hydroperoxide; tert-butyl peracetate; tert-butyl peroxybenzoate; tert-butylperoxy 2-ethylhexyl carbonate; di(2,4-dichlorobenzoyl) peroxide;

®

dichlorobenzoylperoxide (available as Varox DCBP from R. T. Vanderbilt Company, Inc. of Norwalk, Connecticut, USA); di(tert-butylperoxyisopropyl)benzene, di(4-methylbenzoyl) peroxide, butyl 4,4-di(tert-butylperoxy)valerate, 3,3,5,7,7-pentamethyl-1 ,2,4-trioxepane; tert- butyl peroxy-3,5,5-trimethylhexanoate; tert-butyl cumyl peroxide; di(4-tert-butylcyclohexyl) peroxydicarbonate (available as Perkadox 16); dicetyl peroxydicarbonate; dimyristyl peroxydicarbonate; 2,3-dimethyl-2,3-diphenylbutane, dioctanoyl peroxide; tert-butylperoxy 2- ethylhexyl carbonate; tert-amyl peroxy-2-ethylhexanoate, tert-amyl peroxypivalate; and combinations thereof.

[00129] Examples of such thermal radical initiators are commercially available under

®

the following trade names: Luperox sold by Arkema, Inc. of Philadelphia, Pennsylvania, U.S.A.; Trigonox and Perkadox sold by Akzo Nobel Polymer Chemicals LLC of Chicago,

Illinois, U.S.A., VAZO sold by E.I. duPont deNemours and Co. of Wilmington, Delaware,

®

USA; VAROX sold by R.T. Vanderbilt Company, Inc. of Norwalk, Connecticut, U.S.A.; and Norox sold by Syrgis Performance Initiators, Inc. of Helena, Arkansas, U.S.A.

[00130] Alternatively, the curing agent may comprise a room temperature radical initiator such as an organoborane-amine complex. The organoborane amine complex is a complex formed between an organoborane and a suitable amine compound that renders the complex stable at ambient conditions. The complex should be capable of initiating polymerization or crosslinking of component (I) by the introduction of an amine reactive compound and/or by heating. An example is an alkylborane amine complex formed from trialkylboranes and various amine compounds. While the preferred molar ratio can vary, the optimal molar ratio may range from 1 to 10 nitrogen groups per B atom where B represents boron. Examples of trialkylboranes useful for forming the curing agent include trialkylboranes of the formula B-R' 3 where R" represents linear and branched aliphatic or aromatic hydrocarbon groups containing 1 to 20 carbon atoms. Some examples include trimethylborane, tri-n-butylborane, tri-n-octylborane, tri-sec-butylborane, tridodecylborane, and phenyldiethylborane.

[00131] Some examples of amine compounds useful to form the organoborane amine complex with the organoborane compounds include 1 ,3 propane diamine, 1 ,6- hexanediamine, methoxypropylamine, pyridine, and isophorone diamine. Other examples of amine compounds useful to form organoborane amine complexes are described in US Patent 6,777,512 (the '512 patent), as well as in US Patent 6,806,330.

[00132] Silicon containing amine compounds can also be used to form the organoborane amine complex including compositions such as 3- aminopropyltrimethoxysilane, aminomethyltrimethoxysilane, 3-aminopropyltriethoxysilane, aminomethyltriethoxysilane, 2-(trimethoxysilylethyl)pyridine, aminopropylsilanetriol, 3-(m- aminophenoxy)propyltrimethoxysilane, 3-aminopropyldiisopropylmethoxysilane, aminophenyltrimethoxysilane, 3-aminopropyltris(methoxyethoxethoxy)silane, N-(2- aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)aminomethyltrimethoxysilane, N-(6-aminohexyl)aminomethyltrimethoxysilane, N-(2-aminoethyl)-1 1 - aminoundecyltrimethoxysilane, (aminoethylaminomethyl)phenethyltrimethoxysilane, N-(2- aminoethyl)-3-aminopropylmethyldimethoxysilane, N-(2-aminoethyl)-3- aminoisobutylmethyldimethoxysilane, and (3-trimethoxysilylpropyl)diethylene-triamine.

[00133] Amine functional polyorganosiloxanes are also useful for forming the organoborane amine complex including amine functional polydiorganosiloxanes, and amine functional polyorganosiloxane resins. This is subject to the stipulation that the molecule contain at least one amine-functional group, such as 3-aminopropyl, 2-aminoethyl, aminomethyl, 6-aminohexyl, 1 1 -aminoundecyl, 3-(N-allylamino)propyl, N-(2-aminoethyl)-3- aminopropyl, N-(2-aminoethyl)-3-aminoisobutyl, p-aminophenyl, 2-ethylpyridine, and 3- propylpyrrole.

[00134] Specific examples include terminal and/or pendant amine-functional polydimethylsiloxane oligomers and polymers, terminal and/or pendant amine-functional random, graft and block copolymers and co-oligomers of polydimethylsiloxane and poly(3,3,3 trifluoropropyl-methylsiloxane), terminal and/or pendant amine-functional random, graft and block copolymers and co-oligomers of polydimethylsiloxane and poly(6,6,6,5,5,4,4,3,3-nonfluorohexyl-methylsiloxane), and terminal and/or pendant amine- functional random, graft and block copolymers and co-oligomers of polydimethylsiloxane and polyphenylmethylsiloxane.

[00135] Also useful to form the organoborane amine complex are other nitrogen containing compounds including N-(3-triethyoxysilylpropyl)-4,5-dihydroimidazole, ureidopropyltriethoxysilane, nitrogen containing polyorganosiloxanes, and polyorganosiloxane resins in which at least one group is an imidazole, amidine, or ureido functional group. When the amine compound is polymeric, the molecular weight is not limited, except that it should be such as to maintain a sufficiently high concentration of boron to permit curing or polymerization of the composition. For example, in a two-part composition, the part containing the organoborane initiator may be diluted with other components of the composition, or it may consist of the initiator complex alone.

[00136] When an organoborane amine complex is used as the curing agent, the curable silicone composition may further comprise an amine reactive compound that is capable of initiating the polymerization or crosslinking of the composition when mixed with the organoborane amine complex and exposed to an oxygenated environment. The presence of the amine reactive compound allows the initiation of polymerization or crosslinking to occur at temperatures below the dissociation temperature of the organoborane amine complex including room temperature and below. To achieve storage stability in the presence of oxygen, the organoborane amine complex and the amine reactive compound may be physically or chemically isolated. For example, a composition containing an amine reactive compound can be rendered air stable by packaging it separately from the organoborane amine complex as a multiple-part composition. Alternatively, the organoborane amine complex, the amine reactive compound, or both can be encapsulated, or delivered in separate phases. This can be accomplished by introducing one or both of the organoborane amine complex, the amine reactive compound in a solid form that prevents intimate mixing of the organoborane amine complex, the amine reactive compound. Curing of the composition can be activated by (a) heating it above the softening temperature of the solid phase component or encapsulant, or (b) by introduction of a solubilizing agent that allows mixing of the organoborane amine complex, the amine reactive compound. The organoborane amine complex, the amine reactive compound can also be combined in a single container without significant polymerization or crosslinking by packaging the two components in a container where mixing conditions are anaerobic. [00137] Examples of some amine reactive compounds having amine reactive groups that can rapidly initiate polymerization or cure in the presence of oxygen include mineral acids, Lewis acids, carboxylic acids, carboxylic acid derivatives such as anhydrides and succinates, carboxylic acid metal salts, isocyanates, aldehydes, epoxides, acid chlorides, and sulphonyl chlorides. Some suitable amine reactive compounds include acrylic acid, polyacrylic acid, methacrylic acid, polymethacrylic acid, methacrylic anhydride, polymethacrylic anhydride, undecylenic acid, oleic acid, isophorone diisocyanate, methacryloylisocyanate, 2-(methacryloyloxy)ethyl acetoacetate, undecylenic aldehyde, and dodecyl succinic anhydride.

[00138] For improved compatibility in curable silicone compositions the amine reactive compound may be an organosilane or organopolysiloxane bearing amine reactive groups. Some examples include 3-isocyanatopropyltrimethoxysilane; isocyanatomethyltrimethoxysilane; 3-glycidoxypropyltrimethoxysilane; triethoxysilylpropyl succinic anhydride; propylsuccinic anhydride functionalized linear, branched, resinous, and hyperbranched organopolysiloxanes; methylsuccinic anhydride functionalized linear, branched, resinous, and hyperbranched organopolysiloxanes; cyclohexenyl anhydride functional linear, resinous, and hyperbranched organopolysiloxanes; carboxylic acid functionalized linear, branched, resinous, and hyperbranched organopolysiloxanes such as carboxydecyl terminated oligomeric or polymeric polydimethylsiloxanes; and aldehyde functionalized linear, branched, resinous, and hyperbranched organopolysiloxanes such as undecylenic aldehyde-terminated oligomeric or polymeric polydimethylsiloxanes. The '512 patent describes silicon containing compounds that can be used including certain compounds that release an acid when exposed to moisture. The '512 patent also describes other amine reactive compounds referred to as decomplexation agents. Alternatively, the decomplexation agent may be selected from acids, anhydrides, isocaynates, or epoxies. Specific examples include 3-(triethoxysilyl)propylsuccinicanhydride, nonenyl succinic anhydride, acetic acid, 2-carboxyethylacrylate, ethylene glycol methacrylate phosphate, and acrylic acid .

[00139] Alternatively, the room temperature radical initiator comprises a redox reagent as an initiator for radical polymerization. The reagent may be a combination of a peroxide and an amine or a transition metal chelate. The redox reagent is exemplified by, but not limited to, diacyl peroxides such as benzoyl peroxide and acetyl peroxide; hydroperoxides such as cumene hydroperoxide and t-butyl hydroperoxide; ketone peroxides such as methyl ethyl ketone peroxide and cyclohexanone peroxide; dialkyl peroxides such as dicumyl peroxide and ti-t-butyl peroxide; peroxy esters such as t-butyl peroxy acetate; and combinations of thioglycerol and pyrazoles and/or pyrazolones. Alternatively, the redox reagent may be exemplified by dimethylaniline, 3,5-dimethylpyrazole, thioglycerol; and combinations thereof. Examples of suitable redox reagent initiatiors are known in the art and are exemplified as in US Patent 5,459,206. Other suitable peroxides are known in the art and are commercially available such as lauroyl peroxide (Luperox LP from Arkema),

®

dichlorobenzoylperoxide (Varox DCBP from R. T. Vanderbilt Company, Inc.) and 6N tert- butyl hydroperoxide.

[00140] The concentration of the radical initiator (III) may range from 0.01 % to 15 %, alternatively from 0.1 % to 5 %, and alternatively 0.1 % to 2 %, based on the weight of the curable silicone composition.

[00141] The curable silicone composition may optionally include (IV) a moisture cure initiator and (V) a crosslinker and (VI) a moisture cure resin and polymer.

[00142] Component (IV) is a moisture cure initiator (i.e., a condensation catalyst or condensation reaction catalyst). Examples of condensation reaction catalysts are known in the art and are disclosed in U.S. Patents 4,962,076; 5,051 ,455; 5,053,442; 4,753,977 at col. 4, line 35 to col. 5, line 57; and 4,143,088 at col. 7, line 15 to col. 10, line 35. The amount of the condensation reaction catalyst depends on various factors including the type of catalyst selected and the choice of the remaining components in the composition, however the amount of the condensation reaction catalyst may range from 0.001 % to 5 % based on the weight of the curable silicone composition.

[00143] Suitable condensation reaction catalyst (IV) may be a Lewis acid; a primary, secondary, or tertiary organic amine; a metal oxide; a titanium compound; a tin compound; a zirconium compound; or a combination thereof. The condensation reaction catalyst may comprise a carboxylic acid salt of a metal ranging from lead to manganese inclusive in the electromotive series of metals. Alternatively, the condensation reaction catalyst may comprise a chelated titanium compound, a titanate such as a tetraalkoxytitanate, a titanium ester, or a combination thereof. Examples of suitable titanium compounds include, but are not limited to, diisopropoxytitanium bis(ethylacetoacetate), tetrabutoxy titanate, tetrabutyltitanate, tetraisopropyltitanate, and bis-(ethoxyacetoacetonate)diisopropoxy titanium (IV), and a combination thereof. Alternatively the condensation reaction catalyst may comprise a tin compound such as dibutyltin diacetate; dibutyltin dilaurate; dibutyl tin oxide; stannous octoate; tin oxide; a titanium ester, such as tetrabutyl titanate, tetraethylhexyl titanate and tetraphenyltitanate; a siloxytitanate, such as tetrakis(trimethylsiloxy)titanium and bis(trimethylsiloxy)-bis(isopropoxy)titanium; and a betadicarbonyltitanium compound, such as bis(acetylacetonyl)diisopropyl titanate; or a combination thereof. Alternatively, the condensation reaction catalyst may comprise an amine, such as hexylamine; or an acetate or quat salt of an amine.

[00144] Component (V) is a crosslinker. The type and amount of crosslinker will depend on various factors including the type and amount of curable groups based on the curable silicone composition.

[00145] In certain embodiments, the crosslinker (V) is a condensation reaction crosslinker that may be selected from, for example, trialkoxysilanes exemplified by propyltrimethoxysilane, phenyltrimethoxysilane, glycidoxypropyltrimethoxysilane, ethyltrimethoxysilane, aminopropyltrimethoxysilane, aminoethylaminopropyltrimethoxysilane, methyltrimethoxysilane, phenyl trimethoxysilane, and methyltriethoxysilane; acetoxysilanes such as methyltriacetoxysilane or ethyltriacetoxysilane; ketoximosilanes such as methyltri(methylethylketoximo)silane, tetra(methylethylketoximo)silane, methyltris(methylethylketoximo)silane, and vinyltris(methylethylketoximo) silane; alkyl orthosilicates such as tetraethyl orthosilicate, tetramethoxysilane, tetraethoxysilane, and condensation products of these orthosilicates, which are typically referred to as alkyl polysilicates; methylvinyl bis(n-methylacetamido) silane; and a combination thereof.

[00146] In certain embodiments, the amount of crosslinker (V) utilized in the curable silicone composition is dependent upon numerous factors, but is based primarily upon the type and amount of curable groups contained in components (I) and (II). In certain embodiments, the amount of crosslinker is from 0.1 to 10 weight percent, such as from 0.5 to 3 weight percent, based upon the total weight of the curable silicone composition.

[00147] Component (VI) is a moisture cure resin and polymer. In certain embodiments, the moisture cure resin and polymer (VI) comprises:

(a) an organopolysiloxane polymer of the formula (OR⁷)3_-zR⁶ _zSi-Q-

(R25₂Si0₂/2)y-Q-SiR⁷z (OR⁷)_3-Zj

wherein each R²^ j_s independently a monovalent hydrocarbon radical having 1 to 6 carbon atoms, each R⁶ independently is a monovalent hydrocarbon radical having 1 to 6 carbon atoms, each R⁷ independently is selected from the group consisting of a alkyl radical and alkoxyalkyl radical, Q is a divalent linking radical, the subscript z has a value of 0, 1 or 2, and the subscript y has a value of 60 to 1000; and

(b) an alkoxy-functional organopolysiloxane resin comprising a reaction product of a reaction of:

(i) an alkenyl-functional siloxane resin comprising R²⁶3SiO-|/2 units and S1O4/2 units,

wherein each R²^ j_s independently a monovalent hydrocarbon radical having 1 to 6 carbon atoms with the proviso that at least one R²⁶ is an alkenyl radical,

wherein the mole ratio of the R²⁶3SiO-|/2 units to S1O4/2 units has a value of from 0.5/1 to 1 .5/1 ,

(ii) an alkoxysilane-functional organosiloxane compound having at least one silicon-bonded hydrogen atom at a molecular terminal;

(iii) an endcapper;

in the presence of a (iv) hydrosilylation catalyst.

[00148] In certain embodiments, the weight ratio of the polymer (a) to resin (b) in the moisture cure resin and polymer (VI) varies from 75/25 to 35/65.

[00149] The organopolysiloxane polymer (a) of the moisture cure resin and polymer (IV), as noted above, comprises the formula (OR⁷)3_-zR⁶ _zSi-Q-(R²⁵2Si0₂/2)y-Q-SiR⁷ _z (OR⁷)3_-z, wherein each R²⁵ is independently a monovalent hydrocarbon radical having 1 to

6 carbon atoms, each R⁶ independently is a monovalent hydrocarbon radical having 1 to 6 carbon atoms, each R⁷ independently is selected from the group consisting of a alkyl radical and alkoxyalkyl radical, Q is a divalent linking radical, the subscript z has a value of 0, 1 or 2, and the subscript y has a value of 60 to 1000.

[00150] The Q radical is a divalent linking radical linking the silicon atom of the curing radical to a silicon atom of the resin. Q is typically selected from the types of divalent radicals that are used to link silicon atoms in a hydrolytically stable manner and include, but are not limited to, hydrocarbons such as alkylene, for example ethylene, propylene, and isobutylene and phenylene; siloxanes such as, for example, polydimethylsiloxane; and combinations thereof. Preferably, the number of hydrocarbon radical units in the Q divalent linking radical numbers from 2 to 12, alternatively 2, and the number of siloxane radical units in the Q divalent linking radical numbers from 0 to 20, alternatively 2.

[00151] As noted above, the alkoxy-functional organopolysiloxane resin (b) of the moisture cure resin and polymer (VI) includes an alkenyl-functional siloxane compound (i) which, in certain embodiments, includes a resinous portion wherein the R²¾SiO-|/2 units

(i.e., M units) are bonded to the S1O4/2 units (i.e., Q units), each of which is bonded to at least one other S1O4/2 unit. In the R²⁶3SiO-|/2 units, each R²⁶ is individually a monovalent hydrocarbon radical having less than 6 carbon atoms, with the proviso that at least one R²⁶ is an alkenyl radical. Examples of suitable R²⁶ radicals include alkyl radicals, such as methyl, ethyl, propyl, and pentyl; alkenyl radicals, such as vinyl, alkyl, and 5-hexenyl; and aryl radicals such as phenyl.

[00152] At least one third, and more preferably substantially all R²⁶ radicals, are methyl radicals, with the proviso that at least one R radical is an alkenyl radical, and further with the proviso that the resin (i) of the moisture cure resin and polymer (VI) includes from 0.5 to 4 weight percent, alternatively from 1 .0 to 2.2 weight percent, alkenyl-functionality, based on the total weight of the resin (i). Stated differently, the alkenyl radical content of the resin (i) is from .05 to 4 weight percent of the total weight of the resin (i). Examples of preferred R²⁶3SiO-|/2 units having methyl radicals include Me3SiO-|/2 units and

PhMe2SiO-|/2 units, wherein Me is methyl and Ph is phenyl.

[00153] In addition, it is preferable that the hydroxyl content of the resin (i) of the moisture cure resin and polymer (VI) is less than 1 weight percent of the total weight of the resin (i).

[00154] For the purposes of the present invention, the ratio of R²⁶3SiO-|/2 units to

S1O4/2 units in resin (i) of the moisture cure resin and polymer (VI) has a molar ratio of 0.5:1 to 1 .5:1 , respectively. It is preferred that the mole ratio of the total M units to total Q units of the resin (i) be between 0.6:1 and 1 .0:1 . The above M/Q mole ratios can be easily obtained by ²⁹Si nuclear magnetic resonance (NMR) spectroscopy.

[00155] The resin (i) of the moisture cure resin and polymer (VI) preferably has a weight average molecular weight Mw from 12,000 to 30,000 g/mole, typically between 17,000 and 22,000 g/mole. [00156] As noted above, the alkoxy-functional organopolysiloxane resin (b) of the moisture cure resin and polymer (VI) also includes an alkoxysilane-functional organosiloxane compound having at least one silicon-bonded hydrogen atom at a molecular terminal (ii) which, in certain embodiments, is of the general formula HSi(R²⁷)20Si(R²⁷)2CH2CH2Si

R²⁷ _z(OR²⁷)3_-z', wherein R²⁷ is a monovalent hydrocarbon having 1 to 6 carbon atoms and wherein the subscript z' is 0 or 1 .

[00157] Even more preferably, the alkoxysilane-functional organosiloxane compound having at least one silicon-bonded hydrogen atom at a molecular terminal (ii) of the moisture cure resin and polymer (VI) is of the general formula HSi(Me)20Si(Me)2CH2CH2Si (OMe)3, wherein Me is methyl.

[00158] As noted above, the alkoxy-functional organopolysiloxane resin (b) of the moisture cure resin and polymer (VI) also includes an endcapper (iii). The endcapper (iii) is the same endcapper described previously as component i) in the clustered functional polyorganosiloxane (I) above and preferably is of the formula (XVIII), formula (XIX), or a combination thereof.

[00159] As noted above, the alkoxy-functional organopolysiloxane resin and polymer includes a hydrosilylation catalyst (iv) of the moisture cure resin and polymer (VI) which accelerates the reaction of components (i)-(iii). Component (iv) may be added in an amount sufficient to promote the reaction of components (i)-(iii), and this amount may be, for example, sufficient to provide 0.1 parts per million (ppm) to 1000 ppm of platinum group metal, alternatively 1 ppm to 500 ppm, alternatively 2 ppm to 200, alternatively 5 ppm to 150 ppm, based on the combined weight of all components used in the process of making the moisture cure resin and polymer (VI).

[00160] Suitable hydrosilylation catalysts (iv) are known in the art and commercially available. Component (iv) of the moisture cure resin and polymer (IV) may comprise a platinum group metal selected from platinum (Pt), rhodium, ruthenium, palladium, osmium or iridium metal or organometallic compound thereof, or a combination thereof. Component (iv) is exemplified by compounds such as chloroplatinic acid, chloroplatinic acid hexahydrate, platinum dichloride, and complexes of said compounds with low molecular weight organopolysiloxanes or platinum compounds microencapsulated in a matrix or coreshell type structure. Complexes of platinum with low molecular weight organopolysiloxanes include 1 ,3-diethenyl-1 ,1 ,3,3 -tetramethyldisiloxane complexes with platinum. Alternatively, the catalyst may comprise 1 ,3-diethenyl-1 ,1 ,3,3 -tetramethyldisiloxane complex with platinum. When the catalyst is a platinum complex with a low molecular weight organopolysiloxane, the amount of catalyst may range from 0.04 % to 0.4 % based on the combined weight of the components used in the process.

[00161] Suitable hydrosilylation catalysts for component (iv) of the moisture cure resin and polymer (VI) are described in, for example, U.S. Patents 3,159,601 ; 3,220,972; 3,296,291 ; 3,419,593; 3,516,946; 3,814,730; 3,989,668; 4,784,879; 5,036,1 17; and 5,175,325 and EP 0 347 895 B.

[00162] In certain other embodiments, the moisture cure resin and polymer (VI) ranges from 5 to 50 weight percent, alternatively from 15 to 35 weight percent, of the total silicone matrix weight of the curable silicone composition.

[00163] In addition to the optional moisture cure initiator (IV) and crosslinker (V) and moisture cure resin or polymer (VI), in certain embodiments, the curable silicone composition may optionally further comprise one or more additional components. The additional components are exemplified by (VII) a solvent, (VIII) an adhesion promoter, (IX) a colorant, (X) a reactive diluent, (XI) a corrosion inhibitor, (XII) a polymerization inhibitor, and a combination thereof. The curable silicone composition may optionally further comprise (XIII) a filler, (XIV) a filler treating agent, (XV) an acid acceptor; and a combination thereof, for example, if a filler f) has not been added during the process for making the clustered functional polyorganosiloxane, or if more or a different filler is desired to formulate, e.g., the filler (XII) to be added is a thermally conductive filler, described below.

[00164] Component (VII) is a solvent. Suitable solvents are exemplified by organic solvents such as toluene, xylene, acetone, methylethylketone, methyl isobutyl ketone, hexane, heptane, alcohols such as decyl alcohol or undecyl alcohol, and a combination thereof; and non-crosslinkable silicone solvents such as trimethylsiloxy-terminated polydimethylsiloxanes, trimethylsiloxy-terminated polymethylphenylsiloxanes, and a combination thereof. Examples of silicone solvents are known in the art and are

®

commercially available, for example, as Dow Corning OS Fluids from Dow Corning Corporation of Midland, Michigan, U.S.A. The amount of component (VII) may range from 0.001 % to 90 % based on the weight of the curable silicone composition.

[00165] Component (VIII) is an adhesion promoter. Examples of suitable adhesion promoters include an alkoxysilane such as an epoxy-functional alkoxysilane, or a mercapto- functional compound; a combination of an alkoxysilane and a hydroxy-functional polyorganosiloxane; a mercapto-functional compound; an unsaturated compound; an epoxy- functional silane; an epoxy-functional siloxane; a combination, such as a reaction product, of an epoxy-functional silane or epoxy-functional siloxane and a hydroxy-functional polyorganosiloxane; or a combination thereof. Suitable adhesion promoters are known in the art and are commercially available. For example, Silquest A186 is beta-(3,4- epoxycyclohexyl)ethyltrimethoxysilane which is commercially available from Crompton OSi Specialties of Middlebury, Connecticut, USA. CD9050 is a monofunctional acid ester useful as an adhesion promoter that provides adhesion to metal substrates and is designed for radiation curable compositions. CD9050 is commercially available from Sartomer Co. SR489D is tridecyl acrylate, SR395 is isodecyl acrylate, SR257 is stearyl acrylate, SR506 is isobornyl acrylate, SR833S is tricyclodecane dimethanol diacrylate, SR238 is 1 ,6 hexanediol diacrylate, and SR351 is trimethylol propane triacrylate, all of which are also commercially available from Sartomer Co. The amount of adhesion promoter added to the composition depends on various factors including the specific adhesion promoter selected, the other components of the composition, and the end use of the composition, however, the amount may range from 0.1 % to 5 % based on the weight of the composition. Other suitable adhesion promoters, which are useful to promote adhesion to metals, include maleic anhydride, methacrylic anhydride, and glycidyl methacrylate.

[00166] Component (VIII) can be an unsaturated or epoxy-functional compound. Suitable epoxy-functional compounds are known in the art and commercially available, see for example, U.S. Patents 4,087,585; 5,194,649; 5,248,715; and 5,744,507 (at col. 4-5). Component (g) may comprise an unsaturated or epoxy-functional alkoxysilane. For example, the functional alkoxysilane can have the formula R²⁰ _vSi(OR²¹ )(4_-v), where subscript v is 1 , 2, or 3, alternatively v is 1 .

[00167] Each R²⁰ is independently a monovalent organic group with the proviso that at least one R²⁰ is an unsaturated organic group or an epoxy-functional organic group.

Epoxy-functional organic groups for R²⁰ are exemplified by 3-glycidoxypropyl and

(epoxycyclohexyl)ethyl. Unsaturated organic groups for R²⁰ are exemplified by 3- methacryloyloxypropyl, 3-acryloyloxypropyl, and unsaturated monovalent hydrocarbon groups such as vinyl, ally I, hexenyl, undecylenyl. [00168] Each R²¹ is independently an unsubstituted, saturated hydrocarbon group of

1 to 4 carbon atoms, alternatively 1 to 2 carbon atoms. R²¹ is exemplified by methyl, ethyl, propyl, and butyl.

[00169] Examples of suitable epoxy-functional alkoxysilanes include 3- glycidoxypropyltrimethoxysilane, 3-glycidoxypropyltriethoxysilane, (epoxycyclohexyl)ethyldimethoxysilane, (epoxycyclohexyl)ethyldiethoxysilane and combinations thereof. Examples of suitable unsaturated alkoxysilanes include vinyltrimethoxysilane, allyltrimethoxysilane, allyltriethoxysilane, hexenyltrimethoxysilane, undecylenyltrimethoxysilane, 3-methacryloyloxypropyl trimethoxysilane, 3- methacryloyloxypropyl triethoxysilane, 3-acryloyloxypropyl trimethoxysilane, 3- acryloyloxypropyl triethoxysilane, and combinations thereof. Alternatively, examples of suitable adhesion promoters include glycidoxypropyltnmethoxysilane and a combination of glycidoxypropyltnmethoxysilane with an aluminum chelate or zirconium chelate.

[00170] Component (VIII) may comprise an epoxy-functional siloxane such as a reaction product of a hydroxy-terminated polyorganosiloxane with an epoxy-functional alkoxysilane, as described above, or a physical blend of the hydroxy-terminated polyorganosiloxane with the epoxy-functional alkoxysilane. Component (VII) may comprise a combination of an epoxy-functional alkoxysilane and an epoxy-functional siloxane. For example, component (VII) is exemplified by a mixture of 3-glycidoxypropyltrimethoxysilane and a reaction product of hydroxy-terminated methylvinylsiloxane with 3- glycidoxypropyltrimethoxysilane, or a mixture of 3-glycidoxypropyltrimethoxysilane and a hydroxy-terminated methylvinylsiloxane, or a mixture of 3-glycidoxypropyltrimethoxysilane and a hydroxy-terminated methylvinyl/dimethylsiloxane copolymer. When used as a physical blend rather than as a reaction product, these components may be stored separately in multiple-part kits.

[00171] Suitable mercapto-functional compounds include an organomercaptan, a mercapto containing silane, or a combination thereof. Suitable mercapto containing silanes include 3-mercaptopropyltrimethoxysilane. Suitable mercapto-functional compounds are disclosed in U.S. Patent 4,962,076. One skilled in the art would recognize that certain components described herein may be added to the composition for more than one or different purposes. For example, alkoxysilanes may be use as adhesion promoters, filler treating agents, and/or as crosslinking agents in condensation reaction curable silicone compositions.

[00172] Component (IX) is a colorant (e.g., dye or pigment). Examples of suitable colorants include carbon black, Stan-Tone 40SP03 Blue (which is commercially available from PolyOne) and Colorant BA 33 Iron Oxide pigment (which is commercially available from Cathay Pigments (USA), Inc. Valparaiso, IN 46383 USA). Examples of colorants are known in the art and are disclosed in U.S. Patents 4,962,076; 5,051 ,455; and 5,053,442. The amount of colorant added to the curable silicone composition depends on various factors including the other components of the composition, and the type of colorant selected, however, the amount may range from 0.001 % to 20 % based on the weight of the composition.

[00173] Component (X) is a reactive diluent that is different from the silicone reactive diluent (II) described above. Component (X) may be diluent that reacts with a functional group on component (I). The reactive diluent may be a monofunctional reactive diluent, a difunctional reactive diluent, a polyfunctional reactive diluent, or a combination thereof. The reactive diluent selected will depend on various factors including the curable groups on component (I). However, examples of suitable reactive diluents include an acrylate, an anhydride such as a maleic anhydride or methacrylic anhydride, an epoxy such as a monofunctional epoxy compound, a methacrylate such as glycidyl methacrylate, an oxetane, a vinyl acetate, a vinyl ester, a vinyl ether, a fluoro alkyl vinyl ether, a vinyl pyrrolidone such as N-vinyl pyrrolidone, a styrene, or a combination thereof.

[00174] Mono-functional acrylate and methacrylate esters are commercially available from companies such as Sartomer, Rohm Haas, Hitachi Chemical, Arkema, Inc., Cytec, Sans Ester Corp, Rahn, and Bomar Specialties Co. Specific examples include methyl acrylate; methyl methacrylate; ethyl acrylate; ethyl methacrylate; butyl acrylate; butyl methacrylate; cyclohexyl acrylate; hexyl acrylate; 2-ethylhexyl acrylate; isodecyl methacrylate; isobornyl methacrylate; hydroxyethyl methacrylate; hydroxypropyl acrylate; hydroxypropyl methacrylate; n-octyl acrylate; cyclohexyl methacrylate; hexyl methacrylate; 2- ethylhexyl methacrylate; decyl methacrylate; dodecyl methacrylate; lauryl acrylate; tert-butyl methacrylate; acrylamide; N-methyl acrylamide; diacetone acrylamide; N-tert-butyl acrylamide; N-tert-octyl acrylamide; N-butoxyacrylamide; gamma-methacryloxypropyl trimethoxysilane; dicyclopentadienyloxyethyl methacrylate; 2-cyanoethyl acrylate; 3- cyanopropyl acrylate; tetrahydrofurfuryl methacrylate; tetrahydrofurfuryl acrylate; glycidyl acrylate; acrylic acid; methacrylic acid; itaconic acid; glycidyl methacrylate; 1 ,12 dodecanediol dimethacrylate; 1 ,3-butylene glycol diacrylate; 1 ,3-butylene glycol dimethacrylate; 1 ,3-butylene glycol dimethacrylate; 1 ,4-butanediol diacrylate; 1 ,4-butanediol dimethacrylate; 1 ,4-butanediol dimethacrylate; 1 ,6 hexanediol diacrylate; 1 ,6 hexanediol dimethacrylate; alkoxylated cyclohexane dimethanol diacrylate; alkoxylated hexanediol diacrylate; alkoxylated neopentyl glycol diacrylate; cyclohexane dimethanol diacrylate; cyclohexane dimethanol dimethacrylate; diethylene glycol diacrylate; diethylene glycol dimethacrylate; dipropylene glycol diacrylate; ethoxylated bisphenol a diacrylate; ethoxylated bisphenol a dimethacrylate; ethylene glycol dimethacrylate; neopentyl glycol diacrylate; neopentyl glycol dimethacrylate; polypropylene glycoldimethacrylate; propoxylated neopentyl glycol diacrylate; propoxylated neopentyl glycol diacrylate; tricyclodecane dimethanol diacrylate; triethylene glycol diacrylate; trimethylolpropane triacrylate; trimethylolpropane trimethacrylate; tris (2-hydroxy ethyl) isocyanurate triacrylate; tris (2-hydroxy ethyl) isocyanurate triacrylate; n,n'-m-phenylenedimaleimide; triallyl cyanurate; triallyl isocyanurate; metallic diacrylate; metallic dimethacrylate; metallic monomethacrylate; metallic diacrylate (difunctional); metallic dimethacrylate (difunctional); triethoxysilylpropyl methacrylate; tributoxysilylpropyl methacrylate; dimethoxymethylsilylpropyl methacrylate; diethoxymethylsilylpropyl methacrylate; dibutoxymethylsilylpropyl methacrylate; diisopropoxymethylsilylpropyl methacrylate; dimethoxysilylpropyl methacrylate; diethoxysilylpropyl methacrylate; dibutoxysilylpropyl methacrylate; diisopropoxysilylpropyl methacrylate; trimethoxysilylpropyl acrylate; triethoxysilylpropyl acrylate; tributoxysilylpropyl acrylate; dimethoxymethylsilylpropyl acrylate; diethoxymethylsilylpropyl acrylate; dibutoxymethylsilylpropyl acrylate; diisopropoxymethylsilylpropyl acrylate; dimethoxysilylpropyl acrylate; diethoxysilylpropyl acrylate; dibutoxysilylpropyl acrylate; and diisopropoxysilylpropyl acrylate.

[00175] Examples of suitable vinyl ethers include, but are not limited to butanediol divinyl ether, cyclohexanedimethanol divinyl ether, cyclohexanedimethanol monovinyl ether, cyclohexyl vinyl ether, diethyleneglycol divinyl ether, diethyleneglycol monovinyl ether, dodecyl vinyl ether, ethyl vinyl ether, hydroxybutyl vinyl ether, isobutyl vinyl ether, isopropyl vinyl ether, n-butyl vinyl ether, n-propyl vinyl ether, octadecyl vinyl ether, triethyleneglycol divinyl ether, and combinations thereof. Vinyl ethers are known in the art and commercially available from BASF AG of Germany, Europe. The amount of component (IX) depends on various factors such as the specific reactive diluent selected, but the amount may range from 0.5 to 50 % based on the weight of curable silicone composition. One skilled in the art would recognize that some of the reactive diluents described herein (such as the difunctional and polyfunctional acrylates and methacrylates) may also be used in addition to, or instead of, the reactive species described above as component c) of (I).

[00176] Component (XI) is a corrosion inhibitor. Examples of suitable corrosion inhibitors include benzotriazole, mercaptabenzotriazole, mercaptobenzothiazole, and commercially available corrosion inhibitors such as 2,5-dimercapto-1 ,3,4-thiadiazole derivative (CUVAN® 826) and alkylthiadiazole (CUVAN^® 484) from R. T. Vanderbilt. The amount of component (XI) may range from 0.05 % to 0.5 % based on the weight of the curable silicone composition.

[00177] Component (XII) is a polymerization inhibitor. Examples of suitable polymerization inhibitors for acrylate and methacrylate curable groups include, but are not limited to: 2,6,-Di-tert-butyl-4-(dimethylaminomethyl)phenol (DBAP), hydroquinone (HQ); 4- methoxyphenol (MEHQ); 4-ethoxyphenol; 4-propoxyphenol; 4-butoxyphenol; 4- heptoxyphenol; butylated hydroxytoluene (BHT); hydroquinone monobenzylether; 1 ,2- dihydroxybenzene; 2-methoxyphenol; 2,5-dichlorohydroquinone; 2,5-di-tert- butylhydroquinone; 2-acetylhydroquinone; hydroquinone monobenzoate; 1 ,4- dimercaptobenzene; 1 ,2-dimercaptobenzene; 2,3,5-trimethylhydroquinone; 4-aminophenol; 2-aminophenol; 2-N, N-dimethylaminophenol; 2-mercaptophenol; 4-mercaptophenol; catechol monobutylether; 4-ethylaminophenol; 2,3-dihydroxyacetophenone; pyrogallol-1 ,2- dimethylether; 2-methylthiophenol; t-butyl catechol; di-tert-butylnitroxide; di-tert- amylnitroxide; 2,2,6,6-tetramethyl-piperidinyloxy; 4-hydroxy-2,2,6,6-tetramethyl- piperidinyloxy; 4-oxo-2,2,6,6-tetramethyl-piperidinyloxy; 4-dimethylamino-2,2,6,6- tetramethyl-piperidinyloxy; 4-amino-2,2,6,6-tetramethyl-piperidinyloxy; 4-ethanoloxy-2,2,6,6- tetramethyl-piperidinyloxy; 2,2,5,5-tetramethyl-pyrrolidinyloxy; 3-amino-2,2,5,5-tetramethyl- pyrrolidinyloxy; 2,2,5, 5-tetramethyl-1 -oxa-3-azacyclopentyl-3-oxy; 2,2,5,5-tetramethyl-3- pyrrolinyl-1 -oxy-3-carboxylic acid; 2,2,3,3, 5, 5,6, 6-octamethyl-1 ,4-diazacyclohexyl-1 ,4-dioxy; salts of 4-nitrosophenolate; 2-nitrosophenol; 4-nitrosophenol; copper dimethyldithiocarbamate; copper diethyldithiocarbamate; copper dibutyldithiocarbamate; copper salicylate; methylene blue; iron; phenothiazine (PTZ); 3-oxophenothiazine; 5- oxophenothiazine; phenothiazine dimer; 1 ,4-benzenediamine; N-(1 ,4-dimethylpentyl)-N'- phenyl-1 ,4-benzenediamine; N-(1 ,3-dimethylbutyl)-N'-phenyl-1 ,4-benzenediamine; N- nitrosophenylhydroxylamine and salts thereof; nitric oxide; nitrobenzene; p-benzoquinone; pentaerythrityl tetrakis(3-laurylthiopropionate); dilauryl thiodipropionate; distearyll thiodipropionate; ditridecyl thiodipropionate; tetrakis[methylene 3-(3,5-di-tert-butyl-4- hydroxyphenyl)propionate]methane; thiodiethylene bis[3-(3,5-di-tert-butyl-4- hydroxyphenyl)propionate]; octadecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate; isotridecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate; N,N'-hexamethyl (3,5 -di- tertbutyl-4-hydroxyhydrocinnamamide); iso-octyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate; 2,2'-ethylidenebis-(4,6-di-tert-butylphenol); 1 ,3,5-trimethyl-2,4,6-tris(3,5-di-tert- butyl-4-hydroxybenzyl) benzene; 4,6-bis(octylthiomethyl)-o-cresol; triethylene glycol-bis-3-(3- tert-butyl-4-hydroxy-5-methylphenyl)propionate; tris-(3,5-di-tert-butylhydroxybenzyl) isocyanurate; tris(2,4-di-tert-butylphenyl) phosphate; distearyl pentaerythritol diphosphite; bis(2,4-di-tert-butyl phenyl)pentaerythritol diphosphite; 2, 5 -di-tert-amyl-hydroquinone; or isomers thereof; combinations of two or more thereof; or combinations of one or more of the above with molecular oxygen. When present, the polymerization inhibitor may be added to the curable silicone composition in an amount ranging from 100 ppm to 4,000 ppm. Polymerization inhibitors are known in the art and are disclosed, for example in EP 1 359 137.

[00178] Component (XIII) is a filler that may be added if a filler was not used in the process for making the clustered functional polyorganosiloxane, or if additional filler or a different type of filler is desired, such as a thermally conductive filler. The filler may be a filler described above as component e). Alternatively, the filler may be a thermally conductive filler.

[00179] The thermally conductive filler may be both thermally conductive and electrically conductive. Alternatively, the thermally conductive filler may be thermally conductive and electrically insulating. The thermally conductive filler may be selected from the group consisting of aluminum nitride, aluminum oxide, aluminum trihydrate, barium titanate, beryllium oxide, boron nitride, carbon fibers, diamond, graphite, magnesium hydroxide, magnesium oxide, metal particulate, onyx, silicon carbide, tungsten carbide, zinc oxide, and a combination thereof. The thermally conductive filler may comprise a metallic filler, an inorganic filler, a meltable filler, or a combination thereof. Metallic fillers include particles of metals and particles of metals having layers on the surfaces of the particles. These layers may be, for example, metal nitride layers or metal oxide layers on the surfaces of the particles. Suitable metallic fillers are exemplified by particles of metals selected from the group consisting of aluminum, copper, gold, nickel, silver, and combinations thereof, and alternatively aluminum. Suitable metallic fillers are further exemplified by particles of the metals listed above having layers on their surfaces selected from the group consisting of aluminum nitride, aluminum oxide, copper oxide, nickel oxide, silver oxide, and combinations thereof. For example, the metallic filler may comprise aluminum particles having aluminum oxide layers on their surfaces.

[00180] Inorganic fillers are exemplified by onyx; aluminum trihydrate, metal oxides such as aluminum oxide, beryllium oxide, magnesium oxide, and zinc oxide; nitrides such as aluminum nitride and boron nitride; carbides such as silicon carbide and tungsten carbide; and combinations thereof. Alternatively, inorganic fillers are exemplified by aluminum oxide, zinc oxide, and combinations thereof. Meltable fillers may comprise Bi, Ga, In, Sn, or an alloy thereof. The meltable filler may optionally further comprise Ag, Au, Cd, Cu, Pb, Sb, Zn, or a combination thereof. Examples of suitable meltable fillers include Ga, In-Bi-Sn alloys, Sn-ln-Zn alloys, Sn-ln-Ag alloys, Sn-Ag-Bi alloys, Sn-Bi-Cu-Ag alloys, Sn-Ag-Cu-Sb alloys, Sn-Ag-Cu alloys, Sn-Ag alloys, Sn-Ag-Cu-Zn alloys, and combinations thereof. The meltable filler may have a melting point ranging from 50^QC to 250^QC, alternatively 150^QC to 225 ^QC. The meltable filler may be a eutectic alloy, a non-eutectic alloy, or a pure metal. Meltable fillers are commercially available.

[00181] For example, meltable fillers may be obtained from Indium Corporation of America, Utica, N.Y., U.S.A.; Arconium, Providence, R.I., U.S.A.; and AIM Solder, Cranston, R.I., U.S.A. Aluminum fillers are commercially available, for example, from Toyal America, Inc. of Naperville, Illinois, U.S.A. and Valimet Inc., of Stockton, California, U.S.A. Silver filler is commercially available from Metalor Technologies U.S.A. Corp. of Attleboro, Massachusetts, U.S.A.

[00182] Thermally conductive fillers are known in the art and commercially available, see for example, U.S. Patent 6,169,142 (col. 4, lines 7-33). For example, CB-A20S and Al- 43-Me are aluminum oxide fillers of differing particle sizes commercially available from Showa-Denko, DAW-45 is aluminum oxide filler commercially available from Denka, and AA-

04, AA-2, and AA18 are aluminum oxide fillers commercially available from Sumitomo

® ®

Chemical Company. Zinc oxides, such as zinc oxides having trademarks KADOX and XX , are commercially available from Zinc Corporation of America of Monaca, Pennsylvania, U.S.A. [00183] The shape of the thermally conductive filler particles is not specifically restricted, however, rounded or spherical particles may prevent viscosity increase to an undesirable level upon high loading of the thermally conductive filler in the composition.

[00184] The thermally conductive filler may be a single thermally conductive filler or a combination of two or more thermally conductive fillers that differ in at least one property such as particle shape, average particle size, particle size distribution, and type of filler. For example, it may be desirable to use a combination of inorganic fillers, such as a first aluminum oxide having a larger average particle size and a second aluminum oxide having a smaller average particle size. Alternatively, it may be desirable, for example, use a combination of an aluminum oxide having a larger average particle size with a zinc oxide having a smaller average particle size. Alternatively, it may be desirable to use combinations of metallic fillers, such as a first aluminum having a larger average particle size and a second aluminum having a smaller average particle size. Alternatively, it may be desirable to use combinations of metallic and inorganic fillers, such as a combination of aluminum and aluminum oxide fillers; a combination of aluminum and zinc oxide fillers; or a combination of aluminum, aluminum oxide, and zinc oxide fillers. Use of a first filler having a larger average particle size and a second filler having a smaller average particle size than the first filler may improve packing efficiency, may reduce viscosity, and may enhance heat transfer.

[00185] The average particle size of the thermally conductive filler will depend on various factors including the type of thermally conductive filler selected and the exact amount added to the curable silicone composition, as well as the bondline thickness of the device in which the cured product of the composition will be used when the cured product will be used as a thermal interface material (TIM). However, the thermally conductive filler may have an average particle size ranging from 0.1 micrometer to 80 micrometers, alternatively 0.1 micrometer to 50 micrometers, and alternatively 0.1 micrometer to 10 micrometers.

[00186] The amount of the thermally conductive filler in the composition depends on various factors including the cure mechanism selected for the curable silicone composition and the specific thermally conductive filler selected. However, the amount of the thermally conductive filler, if utilized, may range from 30 vol % to 80 vol %, alternatively 50 vol % to 75 vol % by volume of the composition. Without wishing to be bound by theory, it is thought that when the amount of filler is greater than 80 vol %, the composition may crosslink to form a cured silicone with insufficient dimensional integrity for some applications, and when the amount of filler is less than 30 %, the cured silicone prepared from the composition may have insufficient thermal conductivity for TIM applications.

[00187] Component (XIV) is a filler treating agent. The filler treating agent (XIV) may be a filler treating agent described above as the filler treating agent for component e). Alternatively, metal fillers can be treated with alkylthiols such as octadecyl mercaptan and others, and fatty acids such as oleic acid, stearic acid, titanates, titanate coupling agents, zirconate coupling agents, and a combination thereof.

[00188] Filler treating agents for alumina or passivated aluminum nitride may include alkoxysilyl functional alkylmethyl polysiloxanes (e.g., partial hydrolysis condensate of

R²² _wR²³ _xSi(OR²⁴)(4_-w-x) or cohydrolysis condensates or mixtures), or similar materials where the hydrolyzable group may comprise silazane, acyloxy or oximo. In all of these, a group tethered to Si, such as R²² in the formula above, is a long chain unsaturated monovalent hydrocarbon or monovalent aromatic-functional hydrocarbon. Each R²³ is independently a monovalent hydrocarbon group, and each R²⁴ is independently a monovalent hydrocarbon group of 1 to 4 carbon atoms. In the formula above, subscript w is 1 , 2, or 3 and subscript x is 0, 1 , or 2, with the proviso that the sum (w + x) is 1 , 2, or 3. One skilled in the art would recognize that the alkoxysilanes and mercapto-functional compounds described as adhesion promoters for component (VIII) may alternatively be used, in addition to or instead of, filler treating agents for component(XIV). One skilled in the art could optimize a specific treatment to aid dispersion of the filler without undue experimentation.

[00189] Component (XV) is an acid acceptor. The acid acceptor may comprise a metal oxide such as magnesium oxide. Acid acceptors are known in the art and are commercially available under tradenames including Rhenofit F, Star Mag CX-50, Star Mag CX-150, BLP-3, and MaxOx98LR. Rhenofit F was calcium oxide from Rhein Chemie Corporation of Chardon, OH, USA. Star Mag CX-50 was magnesium oxide from Merrand International Corp. of Portsmouth, NH, USA. MagOX 98LR was magnesium oxide from Premier Chemicals LLC of W. Conshohocken, PA, USA. BLP-3 was calcium carbonate was Omya Americas of Cincinnati, OH, USA.

[00190] The curable silicone composition described above may be used in various applications, for example, sealant applications such as forming a lid seal (e.g., automotive lid seal or microelectronics lid seal), forming an adhesive (such as a die attach adhesive or thermally conductive adhesives), or forming a terminal sealant.

[00191] The curable silicone composition described above, and a cured silicone prepared by curing the composition, are useful in electronics applications, including both microelectronics and macroelectronics applications as well as optoelectronics applications and thermally conductive electronics applications, such as making thermally conductive adhesives. Cured silicone adhesives prepared from such a curable silicone compositions may adhere to various electronics substrates, including metals such as aluminum, copper, and electroless nickel; as well as polymeric substrates such as FR4, Nylon, polycarbonate, Lucite (which is polymethylmethacrylate, PMMA), polybutylene terephthalate (PBT), and Solvay liquid crystal polymers.

[00192] So that those skilled in the art can understand and appreciate the invention taught herein, the following examples are presented, it being understood that these examples should not be used to limit the scope of this invention found in the claims attached hereto. All parts and percentages in the examples are on a weight basis and all measurements were obtained at 25° C, unless indicated to the contrary.

Comparative Examples

[00193] These examples are intended to illustrate the invention to one of ordinary skill in the art and should not be interpreted as limiting the scope of the invention set forth in the claims.

29 13

[00194] NMR: Solution-state Si- and C-NMR spectra were recorded on a Mercury VX 400 MHz spectrometer at room temperature (20-22 °C) using CDCI3 (Isotec) in a 16mm Si-free probe. Cr(acac)₃ (Chromium acetylacetonoate) (20 mM) was added to NMR samples

29

as a relaxation agent. Si NMR spectra were acquired at 79.493 MHz and processed with 5 Hz of Lorentzian line broadening. The spectra were only semiquantitative due to the long

29

relaxation times of the Si nucleus, but relative comparison of spectra acquired under

13

identical conditions was considered quantitative. C NMR spectra were acquired at 100.626 MHz and processed with 3 Hz of Lorentzian line broadening. For both nuclei, 256-512 scans with a 90° pulse width were typically co-added to achieve adequate sensitivity; a 6-

29

second ( Si) or 12-second (13C) delay between pulses was used. Gated decoupling was used to remove negative nuclear Overhauser effects. Chemical shifts were referenced to external tetramethylsilane (TMS).

I. List of Components for Examples:

DOW CORNING^® SFD-119; 0.46 wt% vinyl linear polydimethylsiloxane;

DOW CORNING^® SFD-117; 0.2 wt% vinyl linear polydimethylsiloxane;

DOW CORNING^® SFD-120; 0.13wt% vinyl linear polydimethylsiloxane;

DOW CORNING^® SFD-128; 0.088 wt% vinyl linear polydimethylsiloxane;

DOW CORNING^® Q2-5057S; 0.15 wt% Si-H methylhydrogen silicone, linear;

DOW CORNING^® Q2-556S; 0.027 wt% Si-H methylhydrogen silicone, linear;

Methylhydrogensiloxane; 1 .67 wt% Si-H methylhydrogen silicone cyclic;

DOW CORNING^® 2-0707; Platinum catalyst 0.52 wt % Platinum;

MB2030 - (DOW CORNING^® SFD-128/silica blend);

Methyltrimethoxysilane (MTM); DOW CORNING^® Z6070;

OFS-1579 / ETS900 - Mixture of methyl and ethyltriacetoxysilane;

DOW CORNING^® Z-6030 SILANE Methacryloxypropyltrimethoxysilane;

DOW CORNING^® Z-2306 SILANE Isobutyltrimethoxysilane (IBTMS);

DOW CORNING^® Z-6341 SILANE n-octyltriethoxysilane (nOTE);

Diallyl Maleate (DAM) available from from Bimax Inc. of Glen Rock, Pennsylvania;

Allyl methacrylate (AMA) available from BASF Corporation of Florham Park, New

Jersey

Butylated Hydroxy Toluene (BHT) available from from Sigma Aldrich of Milwaukee, Wisconsin;

Magnesium oxide (MAGOX SUPER PREMIUM); available from Premier Magnesia, W. Conshohocken, PA 19428 USAA;

DAW-45; aluminum oxide filler commercially available from Denka;

AL-43-ME; aluminum oxide filler commercially available from Showo-Denko;

CB-A20S; aluminum oxide filler commercially available from Showo-Denko;

Varox^® DCBP-50 Paste; available from R T Vanderbilt Co., Norwalk CT 06856 USA; Perkadox L-50-PS; a product of Azko Nobel Polymer LLC, Chicago IL USA;

TAIC; triallylisocyanurate from Sigma-Aldrich Corp. St. Louis, MO, USA; TYZOR TNBT; available from Dorf Ketal Speciality Catalysts, LLC, 3727 Greenbriar Dr., Stafford, TX 77477 USA;

TINOPAL OB, Optical brightener from BASF Corporation 100 Campus Drive Florham

Park, New Jersey 07932. USA;

®

DOW CORNING TC 1 -4173 is a 1 -part platinum addition-cured thermally conductive adhesive.

II. Impact of Isomer Reducing Agent On Clustered Functional Polyorganosiloxane A. Variation in Amount of Added Isomer Reducing Agent on Generation of T(Oz) and D(Oz) units

[00195] In a dry 3-neck flask, 100g DOW CORNING^® SFD-1 19 (dimethylvinyl- terminated dimethyl siloxane), 6.2 g cyclic methylhydrogensiloxane, 14 g allyl methacrylate (AMA), 0.2 g butylated hydroxytoluene (BHT) and varying amounts of an isomer reducing agent (either OFS-1579, available from Dow Corning Corporation of Midland, Michigan, or DBAP (2,6-Di-tert-butyl-4-(dimethylaminomethyl)phenol) were added and mixed under a nitrogen blanket. 0.12g of a platinum catalyst (DOW CORNING^@2-0707) was added and the mixture was mixed for an additional 5 minutes. The mixture was then heated to 60 °C for 1 hour. The reaction was monitored by the reduction in the Si-H peak at 2173 cm^-1 by IR spectroscopy. The mixture was cooled to room temperature and diallyl maleate (DAM) was added. The reaction mixture was analyzed by ²9Si NMR for the presence of T(Oz) and D(Oz) units. The results are summarized in Tables 1 and 2 below and indicate that the introduction of at least 100 ppm of an isomer reducing agent in the formulation (either OFS- 1579 or DBAP) reduced the level of T(Oz) and D(Oz) units by at least 10%, which corresponds to at least a 10% reduction in the beta-addition of Si-H groups of the methylhydrogensiloxane to the allyl methacrylate.

Table 1

Table 2

B. Viscosity Comparison of Samples With and Without Isomer Reducing Agent (Samples 1 and 2)

[00196] In a 10 liter Turello mixer, 5000g of DOW CORNING^® SFD1 17, 196.34g of cyclic methylhydrogensiloxane, 467.76g of AMA and 1 .13g of BHT were added and mixed for 15 minutes. 5.45g of platinum catalyst was then added and the mixture was mixed for an additional 15 minutes at room temperature. The mixture was heated to 80 °C for 1 hour, wherein samples were evaluated by IR for the disappearance of Si-H signal. At 1 hour the mixture was cooled to less than 45 °C wherein 1 1 .33g of DAM was added. The vacuum was set to 55 mm Hg and the temperature was increased to 80° C and the mixture was stripped for 30 minutes. The resutant composition (Sample 1 ) was cooled to less than 30°C before packaging.

[00197] In a 10 liter Turello mixer, 5000g of DOW CORNING^® SFD1 17, 196.34g of cyclic methylhydrogensiloxane, 467.76g of AMA, 1 .13g of BHT and 1 .13g of OFS-1579 were added and mixed for 15 minutes. 5.45g of platinum catalyst was added and the mixture was mixed for an additional 15 minutes at room temperature. The mixture was heated to 80°C for 1 hour, wherein samples were evaluated by IR for the disappearance of Si-H signal. At 1 hour the mixture was cooled to less than 45 °C wherein 1 1 .33g of DAM was added. The vacuum was set to 55 mm Hg and the temperature was increased to 80 °C and the mixture was stripped for 30 minutes. The resutant composition (Sample 2) was cooled to less than 30 °C before packaging.

[00198] Samples 1 and 2 were measured for viscosity (in centipoises (cps)) using a Brookfield LVF viscometer at 3 revolutions per minute using a #3 spindle. The results, as shown in Table 3, indicate that the introduction of the isomer reducing agent (Sample 2) provided a relatively stable viscosity over a 194 day period, while the viscosity of the corresponding example (Sample 1 ) without the isomer reducing agent increased to almost double the viscosity after 127 days and to the point of gellation after 194 days.

Table 3

III. Impact of Isomer Reducing Agent on a Silicone Reactive Diluent (Samples 1 and 2)

[00199] In a 50 liter Turello mixer, 6196.7 g of chain extender Q2-5567S, 1 .3 g of BHT, and 318.69 g of AMA were loaded. The mixture was inerted using 2% oxygen in nitrogen atmosphere and stirred for 10 minutes, at which point 6.64 g of a platinum catalyst was added. The mixture was stirred for 10 additional minutes before setting the temperature at 50 °C. The temperature was held for 30 minutes at 50°C before adding 9.96 g of DAM. The mixture was stirred for 10 additional minutes. The temperature was held for 30 minutes at 50 °C at a vacuum of 75 Torr. The resutant composition (Sample 1 ) was cooled to less than 30 °C before packaging.

[00200] In a 50 liter Turello mixer, 6196.7 g of chain extender Q2-5567S, 1 .3 g of BHT, 318.69 g of AMA, and 1 .3g of OFS-1579 isomer reducing agent were loaded. The mixture was inerted using 2% oxygen in nitrogen atmosphere and stirred for 10 minutes, at which point 6.64 g of a platinum catalyst was added. The mixture was stirred for 10 additional minutes before setting the temperature at 50 °C. The temperature was held for 30 minutes at 50 °C before adding 9.96 g of DAM. The mixture was then stirred for 10 additional minutes. The temperature was held for 30 minutes at 50 °C at a vacuum of 75 Torr. The resutant composition (Sample 2) was cooled to less than 30 °C before packaging.

[00201] Samples 1 and 2 were measured for viscosity (in centipoises (cps)) using a Brookfield LVF viscometer at 60 revolutions per minute using a #3 spindle. The results, as shown in Table 3, indicate that the introduction of the isomer reducing agent (Sample 2) provided a relatively stable viscosity over a 90 days period, while the viscosity of the corresponding example (Sample 1 ) without the isomer reducing agent increased to almost double the viscosity after 90 days. Table 4

IV. Preparation of thermally conductive thermal radical cure silicone adhesive

A. Preparation of Methacrylate Clustered Silicone Polymers From a Masterbatch with (MCP-1 ) and without (MCP) Isomer Reducing Agent.

[00202] In a 50 liter Turello mixer, 12 kg of a silicone polymer masterbatch (MB2030) (SFD-128/silica blend), 6.77 kg of SFD120 polymer, 1 .12 kg of OS20 silicone fluid (methylsiloxane fluid available from Dow Corning Corporation of Midland, Ml) and 20.45 g of OFS-1579 isomer reducing agent were loaded. The mixture was inerted using 2% oxygen in nitrogen atmosphere and stirred for 15 minutes. To this homogenized mixture was added 6 g of BHT, 409.7 g of cyclic methylhydrogensiloxane, and 965.3 g of AMA. The resultant mixture was stirred for an additional 20 minutes at room temperature, at which point 26.62 g of a platinum catalyst was added. The mixture was stirred for 10 additional minutes before setting the temperature at 60 °C. The temperature was held for 30 minutes at 60 °C before cooling to greater than 40 °C and adding 26.62 g of DAM. The mixture was then cooled to less than 35 °C before adding 182.8 g of methyltrimethoxysilane (MTM). The mixture was then heated to 60 °C and held for 30 minutes, wherein the temperature was increased to 80 °C and a vacuum of 55 mm Hg was applied for 40 minutes. The resultant polymer is hereinafter referred to as MCP-1 .

[00203] For producing the MCP resin without an isomer reducing agent, the same procedure was followed as in the previous paragraph with the exception of the addition of 20.45 g of OFS-1579 isomer reducing agent.

B. Preparation of Methacrylate Clustered Silicone Polymers Without A Masterbatch and with an Isomer Reducing Agent (MCP-2).

[00204] In a 50 liter Turello mixer, 6 kg of DOW CORNING^® SFD120 polymer, 176.92g of cyclic methylhydrogensiloxane, and 274.74 g of chain extender Q2-5057S were loaded. The mixture was inerted using 2% oxygen in nitrogen atmosphere and stirred for 10 minutes. A homogenized mixture included 1 .08 g of BHT, 537.58 g of AMA, and 1 .08g of OFS-1579 isomer reducing agent was introduced to the mixture. The resultant mixture was stirred for an additional 10 minutes at room temperature, at which point 8.03 g of a platinum catalyst was added. The mixture was stirred for 10 additional minutes before setting the temperature at 80 °C. The temperature was held for 30 minutes at 80 °C before cooling to lower than 50 °C and adding 12.05 g of DAM. The mixture was stirred for 10 additional minutes before setting the temperature at 80 °C. The temperature was held for 30 minutes at 80 °C at a vacuum of 75 Torr. The mixture was then cooled to less than 35 °C. The resultant polymer is hereinafter referred to as MCP-2.

C. Synthesis of Silicone Reactive Diluent (SRD-1 )

[00205] In a 50 liter Turello mixer, 6196.7 g of chain extender Q2-5567S, 1 .3 g of BHT, 318.69 g of AMA, and 1 .3g of OFS-1579 isomer reducing agent were loaded. The mixture was inerted using 2% oxygen in nitrogen atmosphere and stirred for 10 minutes, at which point 6.64 g of a platinum catalyst was added. The mixture was stirred for 10 additional minutes before setting the temperature at 50 °C. The temperature was held for 30 minutes at 50 °C before adding 9.96 g of DAM. The mixture was stirred for 10 additional minutes. The temperature was held for 30 minutes at 50°C at a vacuum of 75 Torr. The mixture was then cooled to less than 35 °C. The resultant polymer is hereinafter referred to as SRD-1 .

D. Preparation of Thermally Conductive Adhesives (TCA) Using Premade Silicone Polymers

[00206] In a 1 quart Gallon Baker Perkin mixer, 75.27 g of MCP-2, 128.53 g of SRD-1 ,

461 .06 g of AI-43-ME (AI203 filler), and 19.52 g of DOW CORNING^® Z-6341 (filler treat agent) were loaded. The mixture was stirred for 30 minutes before setting the temperature at 90 °C. The temperature was held for 30 minutes at 90 °C with a vacuum before cooling to lower than 50°C. 691 .58 g of DAW-45 (Al O filler) and 3.45 g of MgO_≥ were added. The mixture (M-1 ) was mixed for 30 minutes at room temperature (<30°C) with a vacuum. Adhesive compositions were prepared by further adding promoter packages and radical initiators as provided in Table 5 below. Z-6030 was loaded in 2 steps to reach the total amount described in Table 4. In between the 2-step loading, there was 30 minutes of mixing at room temperature.

[00207] In a 1 quart Gallon Baker Perkin mixer, 166.12 g of MCP-2, 1058.47 g of Al-

43-ME (Al₂0₃ filler), 105.85 g of DAW-45 (Al O filler) and 38.26 g of DOW CORNING^® Z-

6341 (filler treat agent) were loaded. During the loading, AI-43-ME and Z-6341 were loaded in 3 steps to reach the total amount described above. In between the 3-step loadings, there was 2-5 minutes of mixing at room temperature to mesh in the fillers. After all the components (described above) added in the mixer, the mixture (M-2) was stirred for 20 minutes before setting the temperature at 90 °C. The temperature was held for 30 minutes at 90°C with a vacuum. The mixture (M-2) was cooled to lower than 30°C before packaging. 663.6 g of this mixture (M-2), 717.7 g of DAW-45 (Al O filler), 3.88 g of MgO_≥ and 150 g of

SRD-1 were added in a 1 quart Gallon Baker Perkin mixer. The mixture (M-3) was mixed for 30 minutes at room temperature (<30 °C) with a vacuum. Adhesive compositions were prepared by further adding promoter packages and radical initiators as provided in Table 5 below.

E. Preparation of Thermally Conductive Adhesives (TCA) Using Premade Silicone Polymers and Pretreated Thermally Conductive Fillers

[00208] In a 100max dental cup, 14.5 g of a mixture of MCP-2 and SRD-1 was made at various weight ratios (60:40, 50:50, 40:60 and 35:65 respectively). 49.8 g of CB-A20S (pretreated with Z-6341 ), 33.2 g of AI-43-ME (pretreated with Z-6341 ) and 0.5 g of MgO were added to this mixture. The mixture (M-4) was mixed at 2000 rpm for 15 seconds, and repeated mixing 2 more times with 10 minutes in between. Adhesive compositions were prepared by further adding promoter packages and radical initiators as provided in Table 5 below.

Table 5 Thermally conductive adhesive (TCA) formulation (unit in gram)

Evaluation of Physical Properties of Adhesive Composition

[00209] Viscosity measurement on TCA formulations: In the following examples, a Brooksfield cone and plane viscometer (DV-II, spindle #52, speed 2 rpm) and a Brooksfield RVF viscometer (spindle #7, speed 2 rpm (low shear) and 20 rpm (high shear)) were utilized to determine the viscosity of the various thermally conductive adhesive formulations.

TM TM

[00210] Sample preparation on Alclad Panels: 1 " x 3" Al Alclad Panels (available from Alcoa) were cleaned with acetone (3 samples prepared). Bondlines were established using Spheriglass spacer beads (Potters Industries Inc. 350 North Baker Drive, Canby, OR 97013-0607) appropriate with the application (i.e, 23 mil).

TM

[00211] Next, the adhesives were applied to Alclad aluminum substrates. Two 3/8" binder clip were used with spacer methods to secure substrates during cure. The Cure condition is 30 minutes at 85° C. One half of the samples were evaluated at room temperature and aged, while the remaining samples were placed in 150°C oven for 3 days.

[00212] Testing was carried out on Instron 5566 tensiometer at 2 inches per minute (!nstron Worldwide Headquarters, 825 University Ave., Norwood, MA 02062-2643). The lap shear adhesive properties of the coated substrates were evaluated for peak stress, in pounds per square inch (PSI), with the results summarized in Table 6-8 below.

[00213] Preparation of thermally conductive adhesive (TCA) formulation samples for physical test and thermal conductivity: The TCA material in dental cup was removed from a freezer and allowed to warm up to near room temperature for at least one hour. The cup of material was then placed in chamber and full vacuum was pulled for 15 minutes. Approximately 56-58g of the material was then poured carefully into 4" x 4" x 0.075" chase to try and minimize introduction of air into the material. The chase was used along with Teflon sheets on each side to help with the release of material and to produce smooth surfaces, and two backing plates were used to help shape the slab. The chase, between the two backing plates was then placed into a Dake hot press at 85°C and 10 tons of force was applied for 30 minutes.

[00214] After cure, material was removed from the hot press and allowed to cool to room temperature. Then, the slab of material was trimmed around the edges and removed from the chase. From this slab, using a "dogbone" shaped cutter and press, 5 samples were cut for tensile and elongation testing. Three (labeled RT samples) were tested 24 hours after o

cure. The remaining two samples were exposed to 150 C for 3 days before testing and were labeled TRT samples.

[00215] The Instron T2000 tensometer was used to perform the physical testing, with the test program titled "Standard Tensile Test". The leftovers from the slab (pieces that were not pulled) were utilized for Durometer and thermal conductivity measurement. The stack of three pieces reached 6mm thickness (ref as the stack). For Shore A Durometer, 5 readings were taken. For HotDisk thermal tester (TPS 2500S Therm Test Inc), two stacks were placed on the top and bottom of thermal test probe. The measurement was taken with the setting as output powder 0.25w and time measure 10 s.

Table 6 TCA from M-4 in Table 5 with various ration between MCP-2 and SRD-1

[00216] As Table 6 confirms, the introduction of the silicone reactive diluent to the adhesive formulations resulted in a significant reduction in the viscosity while retaining the low temperature cure profile and slightly reduced elongation.

Table 7 TCA in Table 5 viscosity (before cure)

[00217] As Table 7 confirms, the adhesive compositions (Table 5 Adhesives) according to the present invention exhibited similar viscosity at high shear that were achieved by compositions of the invention, relative to hydrosilylation cured compositions containing similar filler contents and loadings. The viscosity at low shear was lower than TC 1 -4173. Table 8 Properties after cure.

[00218] As Table 8 confirms, the adhesive composition (Table 5 Adhesives) according to the present invention exhibited >1 .5W/mK thermal conductivity, adequate physical properties in terms of Durometer hardness, tensile strength, elongation, and lap shear on

TM

Alclad Al substrates. In addition, the adhesive composition (Table 5 Adhesives) according to the present invention cured at lower temperatures (actual cure condition or bond line cure condition) than platinum catalyzed addition chemistry adhesive systems. The introduction of silicone reactive diluents to the adhesive formulation retained the cure profile at low temperature (85 °C for 30 minutes).

[00219] The instant disclosure has been described in an illustrative manner, and it is to be understood that the terminology which has been used is intended to be in the nature of words of description rather than of limitation. Obviously, many modifications and variations of the instant disclosure are possible in light of the above teachings. It is, therefore, to be understood that within the scope of the appended claims, the instant disclosure may be practiced otherwise than as specifically described.

Claims

1 . A curable silicone composition comprising a reaction product of a reaction of:

(I) a clustered functional polyorganosiloxane having at least one radical curable group selected from an acrylate group and a methacrylate group that comprises a reaction product of a reaction of:

b) a first polyorganohydrogensiloxane having an average, per molecule, of 4 to 15 silicon atoms and at least 4 silicon bonded hydrogen atoms per aliphatically unsaturated organic group in component a),

c) a first reactive species having, per molecule at least one aliphatically unsaturated organic group and one or more curable groups selected from acrylate groups and methacrylate groups,

in the presence of d) a first hydrosilylation catalyst and e) a first isomer reducing agent;

(II) a silicone reactive diluent comprising a reaction product of a reaction of:

a) a second polyorganohydrogensiloxane having an average of 10 to 200 silicon atoms per molecule, and

b) a second reactive species having, per molecule, at least 1 aliphatically unsaturated organic group and 1 or more curable groups,

in the presence of c) a second isomer reducing agent and d) a second hydrosilylation catalyst; and

(III) a radical initiator.

2. A curable silicone composition comprising a reaction product of a reaction of:

a) a polyorganosiloxane having an average, per molecule, of at least 2 aliphatically unsaturated organic groups, b) a first polyorganohydrogensiloxane having an average, per molecule, of 4 to 15 silicon atoms and at least 4 silicon bonded hydrogen atoms per aliphatically unsaturated organic group in component a),

a) a second polyorganohydrogensiloxane of the formula HR₂SiO-(R₂SiO)_a-

SiR₂H, where each R is independently a monovalent hydrocarbon group and wherein the subscript a has an average value ranging from 0 to 400, and

(III) a radical initiator.

3. The curable silicone composition as set forth in claim 1 or claim 2, wherein the

3 4

second reactive species comprises a silane according to the formula R _dSiR ; wherein the

3

subscript d has a value ranging from 1 to 3 and wherein each R is independently an

4

aliphatically unsaturated organic group and wherein each R is independently selected from an organic group containing an acrylate group and a methacrylate group.

4. The curable silicone composition as set forth in any one of claims 1 to 3, wherein the second reactive species comprises an organic compound which does not contain a silicon atom and has an average per molecule of 1 to 2 aliphatically unsaturated organic groups and one or more reactive groups selected from an acrylate group and a methacrylate group.

5. The curable silicone composition as set forth in any one of claims 1 to 4, wherein the second isomer reducing agent is present in an amount based on the silicone reactive diluent to produce at least a 10% reduction in the beta-addition of Si-H groups of the second polyorganohydrogensiloxane to the aliphatically unsaturated organic group of the second reactive species as compared to a silicone reactive diluent formed in the absence of the second isomer reducing agent.

6. A curable silicone composition comprising a reaction product of a reaction of:

a) a first polyorganosiloxane having an average, per molecule, of at least 2 aliphatically unsaturated organic groups,

b) a polyorganohydrogensiloxane having an average, per molecule, of 4 to 15 silicon atoms and at least 4 silicon bonded hydrogen atoms per aliphatically unsaturated organic group in component a),

c) a reactive species having, per molecule at least one aliphatically unsaturated organic group and one or more curable groups selected from acrylate groups and methacrylate groups,

in the presence of d) a first hydrosilylation catalyst and e) an isomer reducing agent;

a) a siloxane compound according to the formula:

wherein:

each R is independently a monovalent hydrocarbon having 1 to 6 carbon atoms,

R' is a monovalent hydrocarbon having 3 to 12 carbon atoms.

R" is H or CH , and

3'

the subscripts m and n each independently have a value from 1 to 10, and

b) a second polyorganosiloxane having an average, per molecule, of at least 2 aliphatically unsaturated organic groups,

in the presence of c) a second hydrosilylation catalyst and d) an inhibitor for the second hydrosilylation catalyst; and (III) a radical initiator.

7. The curable silicone composition as set forth in claim 6, wherein the isomer reducing agent e) is present in an amount based on the total weight of the clustered functional polyorganosiloxane to produce at least a 10% reduction in the beta-addition of Si-H groups of the first polyorganosiloxane to the aliphatically unsaturated group of the reactive species as compared to a clustered functional polyorganosiloxane formed in the absence of the isomer reducing agent.

8. A method for forming a cured substrate, the method comprising:

applying a curable silicone composition according to any one of claims 1 to 7 to a substrate; and

curing the curable silicone compositon on the substrate to form the cured substrate.

9. Use of the curable silicone composition as set forth in any one of claims 1 to 7 in an electronics application.

10. A silicone reactive diluent comprising a reaction product of a reaction of:

a) a polyorganohydrogensiloxane having an average of 10 to 200 silicon atoms per molecule, and

b) a reactive species having, per molecule, at least 1 aliphatically unsaturated organic group and 1 or more curable groups,

in the presence of c) an isomer reducing agent and d) a hydrosilylation catalyst.

1 1 . The silicone reactive diluent as set forth in claim 10 wherein the polyorganohydrogensiloxane comprises the formula Si-

(OSiR² ₂)_b(OSiHR²)_b,(OSiR² ₃)_c(OSiR² ₂H)_{(4 c)}, wherein each R² is independently a monovalent organic group free of aliphatic unsaturation, subscript b has a value ranging from 0 to 10, subscript b' has a value ranging from 0 to 10, and subscript c has a value ranging from 0 to 1 .

12. A silicone reactive diluent comprising a reaction product of a reaction of:

a) a polyorganohydrogensiloxane of the formula HR₂SiO-(R₂SiO)_a-SiR₂H, where each R is independently a monovalent hydrocarbon group and wherein the subscript a has an average value ranging from 0 to 400, and

b) a reactive species having, per molecule, at least 1 aliphatically unsaturated organic group and 1 or more curable groups, in the presence of c) an isomer reducing agent and d) a hydrosilylation catalyst.

13. The silicone reactive diluent as set forth in any one of claims 10 to 12, wherein the

3 4

reactive species comprises a silane according to the formula R _dSiR _{(3 d)} wherein the

3

4

14. The silicone reactive diluent as set forth in any one of claims 10 to 13, wherein the reactive species comprises an organic compound which does not contain a silicon atom and has an average per molecule of 1 to 2 aliphatically unsaturated organic groups and one or more reactive groups selected from an acrylate group and a methacrylate group.

15. The curable silicone composition as set forth in any one of claims 10 to 14, wherein the isomer reducing agent is present in an amount based on the silicone reactive diluent to produce at least a 10% reduction in the beta-addition of Si-H groups of the polyorganohydrogensiloxane to the aliphatically unsaturated organic group of the reactive species as compared to a silicone reactive diluent formed in the absence of the isomer reducing agent.

16. Use of the silicone reactive diluent as set forth in any one of claims 10 to 15 in an electronics application.

17. A filled curable silicone composition comprising a filler and a curable silicone composition prepared by the process of any one of claims 1 to 7.

18. The filled curable silicone composition of claim 17, where the filler comprises a thermally conductive filler.

19. The filled curable silicone composition of claim 17 or claim 18, where the filled curable silicone composition further comprises one or more components selected from (IV) a moisture cure catalyst, (V) a crosslinker, (VI) a moisture cure resin and polymer, (VII) a solvent, (VIII) an adhesion promoter, (IX) a colorant, (X) a reactive diluent, (XI) a corrosion inhibitor, (XII) a polymerization inhibitor, (XIV) a filler treating agent, (XV) an acid acceptor, and a combination thereof.

20. Use of the filled curable silicone composition as set forth in any one of claims 17 to 19 in an electronics application.